Miyawaki T, Kenmotsu H, Doshita K, Kodama H, Nishioka N, Iida Y, Miyawaki E, Mamesaya N, Kobayashi H,
Omori S, Ko R, Wakuda K, Ono A, Naito T, Murakami H, Mori K, Harada H, Endo M, Takahashi K, Takahashi T.
Clinical impact of tumour burden on the efficacy of PD-1/PD-L1 inhibitors plus chemotherapy in
non-small-cell lung cancer. Cancer Med. 12(2):1451-1460, 2023 Jan
Tomofuji Y, Suzuki K, Kishikawa T, Shojima N, Hosoe J, Inagaki K, Matsubayashi S, Ishihara H, Watada H,
Ishigaki Y; BioBank Japan Project; Inohara H, Murakami Y, Matsuda K, Okada Y, Yamauchi T, Kadowaki T.
Identification of serum metabolome signatures associated with retinal and renal complications of type 2
diabetes. Commun Med (Lond). 3(1):5, 2023 Jan
Takahashi M, Saito K, Ai T, Nojiri S, Khasawneh A, Paran FJ, Horiuchi Y, Takei S, Yamamoto T, Wakita M,
Hiki M, Miida T, Naito T, Takahashi K, Tabe Y. Performance evaluation of the Ortho VITROS SARS-CoV-2
Spike-Specific Quantitative IgG test by comparison with the surrogate virus neutralizing antibody test
and clinical assessment. PLoS One. 18(1): e0279779, 2023 Jan
Fukushima T, Chubachi S, Namkoong H, Asakura T, Tanaka H, Lee H, Azekawa S, Okada Y, Koike R, Kimura A,
Imoto S, Miyano S, Ogawa S, Kanai T, Fukunaga K; Japan COVID-19 Task Force. Clinical significance of
prediabetes, undiagnosed diabetes and diagnosed diabetes on critical outcomes in COVID-19: Integrative
analysis from the Japan COVID-19 task force. Diabetes Obes Metab. 25(1):144-155, 2023 Jan
Kurokawa K, Mitsuishi Y, Shimada N, Ito N, Ogiwara M, Miura K, Asao T, Ko R, Shukuya T, Shibayama R,
Goto H, Takahashi K. Clinical characteristics of adrenal insufficiency induced by pembrolizumab in
non-small-cell lung cancer. Thorac Cancer. 14(5):442-449, 2023 Feb
Watanabe J, Ihara H, Takei S, Nakamura A, Fujimoto Y, Handoh T, Kurokawa K, Arai Y, Shibayama K,
Sumiyoshi I, Ochi Y, Okabe T, Misawa S, Togo S, Naito T, Tabe Y, Miida T, Takahashi K. The synergetic
effect of sitafloxacin-arbekacin combination in the Mycobacterium abscessus species. Sci Rep.
13(1):2027, 2023 Feb
Xu S, Miura K, Shukuya T, Harada S, Fujioka M, Winardi W, Shimamura S, Kurokawa K, Sumiyoshi I, Miyawaki
T, Asao T, Mitsuishi Y, Tajima K, Takahashi F, Hayashi T, Harada N, Takahashi K. Early Detection of
Therapeutic Benefit from PD-1/PD-L1 Blockade in Advanced Lung Cancer by Monitoring Cachexia-Related
Circulating Cytokines. Cancers (Basel). 15(4):1170, 2023 Feb
Jo H, Yoshida T, Yagishita S, Ohuchi M, Matsumoto Y, Shinno Y, Okuma Y, Goto Y, Horinouchi H, Yamamoto
N, Takahashi K, Motoi N, Hamada A, Ohe Y. Clinical Characteristics and Pharmacokinetics Change of
Long-Term Responders to Antiprogrammed Cell Death Protein 1 Inhibitor Among Patients With Advanced
NSCLC. JTO Clin Res Rep. 4(4):100474, 2023 Feb
Kuroda Y, Kaneko T, Yoshikawa H, Uchiyama S, Nagata Y, Matsushita Y, Hiki M, Minamino T, Takahashi K,
Daida H, Kagiyama N. Artificial intelligence-based point-of-care lung ultrasound for screening COVID-19
pneumoniae: Comparison with CT scan. PLOS ONE. 18(3): e0281127, 2023 Mar
Sandhu Y, Harada N, Sasano H, Harada S, Ueda S, Takeshige T, Tanabe Y, Ishimori A, Matsuno K, Abe S,
Nagaoka T, Ito J, Chiba A, Akiba H, Atsuta R, Izuhara K, Miyake S, Takahashi K. Pretreatment Frequency
of Circulating Th17 Cells and FeNO Levels Predicted the Real-World Response after 1 Year of Benralizumab
Treatment in Patients with Severe Asthma. Biomolecules. 13(3): 538, 2023 Mar
Sekimoto Y, Sekiya M, Nojiri S, Hayakawa E, Masui Y, Tajima M, Nishino K, Nishizaki Y, Takahashi K.
IFN-l3 and CCL17 as predictors of disease progression in patients with mild to moderate COVID-19: A
cohort study in a real-world setting. Respir Investig. 61(2):153-156, 2023 Mar
Miyamoto A, Michimae H, Nakahara Y, Akagawa S, Nakagawa K, Minegishi Y, Ogura T, Hontsu S, Date H,
Takahashi K, Homma S, Kishi K; Investigators Group for Lung Cancer and IIP. Chemotherapy versus best
supportive care in advanced lung cancer and idiopathic interstitial pneumonias: A retrospective
multi-centre cohort study. Respir Investig. 61(2):284-295, 2023 Mar
Kanamori R, Yan Y, Ito K, Fukuda H, Hori S, Yamamoto T, Igawa G, Saito K, Horiuchi Y, Nojiri S,
Nishizaki Y, Tabe Y, Takahashi K, Naito T. Increased SARS-CoV-2 seroprevalence and spread of infection
without awareness among healthcare workers through 2020-2022 in a Japanese medical center. Sci Rep.
13(1):4941, 2023 Mar
Watase M, Masaki K, Chubachi S, Namkoong H, Tanaka H, Lee H, Fukushima T, Otake S, Nakagawara K,
Kusumoto T, Asakura T, Kamata H, Ishii M, Hasegawa N, Oyamada Y, Harada N, Ueda T, Ueda S, Ishiguro T,
Arimura K, Saito F, Yoshiyama T, Nakano Y, Mutoh Y, Suzuki Y, Edahiro R, Sano H, Sato Y, Okada Y, Koike
R, Kitagawa Y, Tokunaga K, Kimura A, Imoto S, Miyano S, Ogawa S, Kanai T, Fukunaga K; Japan COVID-19
Task Force. Impact of accumulative smoking exposure and chronic obstructive pulmonary disease on
COVID-19 outcomes: report based on findings from the Japan COVID-19 task force. Int J Infect Dis.
128:121-127, 2023 Mar
Nishioki T, Koyama R, Okubo H, Fukuo Y, Takasaki Y, Yae T, Banno T, Kenji K, Takahashi K, Shiina S,
Ikejima K. Endobronchial Watanabe Spigot Placement for Hepatic Abscess and Bronchobiliary Fistula
Following Radiofrequency Ablation for Hepatocellular Carcinoma. Intern Med, 62(7): 999-1004, 2023 Apr
Kanamori K, Suina K, Shukuya T, Takahashi F, Hayashi T, Hara K, Saito T, Mitsuishi Y, Shimamura SS,
Winardi W, Tajima K, Ko R, Mimori T, Asao T, Itoh M, Kawaji H, Suehara Y, Takamochi K, Suzuki K,
Takahashi K. CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from
type B3 thymoma. Thorac Cancer. 14(12):1089-1097, 2023 Apr
Edahiro R, Shirai Y, Takeshima Y, Sakakibara S, Yamaguchi Y, Murakami T, Morita T, Kato Y, Liu YC,
Motooka D, Naito Y, Takuwa A, Sugihara F, Tanaka K, Wing JB, Sonehara K, Tomofuji Y; Japan COVID-19 Task
Force; Namkoong H, Tanaka H, Lee H, Fukunaga K, Hirata H, Takeda Y, Okuzaki D, Kumanogoh A, Okada Y.
Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severity.
Nat Genet. 55(5):753-767, 2023 May
Handa T, Hayashi T, Ura A, Watanabe I, Takamochi K, Onagi H, Kishi M, Matsumoto N, Tajima K, Kishikawa
S, Saito T, Takahashi K, Suzuki K, Yao T. Comparison of ASCL1, NEUROD1, and POU2F3 expression in
surgically resected specimens, paired tissue microarrays, and lymph node metastases in small cell lung
carcinoma. Histopathology. 82(6):860-869, 2023 May
Saito R, Sugawara S, Ko R, Azuma K, Morita R, Maemondo M, Oizumi S, Takahashi K, Kagamu H, Tsubata Y,
Seike M, Kikuchi T, Okamoto I, Satoshi M, Asahina H, Tanaka K, Sugio K, Kobayashi K. Phase 2 study of
osimertinib in combination with platinum and pemetrexed in patients with previously untreated
EGFR-mutated advanced non-squamous non-small cell lung cancer: The OPAL Study. Eur J Cancer. 185:83-93,
2023 May
Komura M, Sato T, Suzuki Y, Yoshikawa H, Nitta NA, Hayashi M, Kuwasaki E, Horikoshi K, Nishioki T, Mori
M, Kodama Y, Sasaki S, Takahashi K. Blood Eosinophil Count as a Predictive Biomarker of Chronic
Obstructive Pulmonary Disease Exacerbation in a Real-World Setting. Can Respir J. 2023:3302405, 2023 May
Azekawa S, Chubachi S, Asakura T, Namkoong H, Sato Y, Edahiro R, Lee H, Tanaka H, Otake S, Nakagawara K,
Fukushima T, Watase M, Sakurai K, Kusumoto T, Masaki K, Kamata H, Ishii M, Hasegawa N, Okada Y, Koike R,
Kitagawa Y, Kimura A, Imoto S, Miyano S, Ogawa S, Kanai T, Fukunaga K; Japan COVID-19 Task Force. Serum
KL-6 levels predict clinical outcomes and are associated with MUC1 polymorphism in Japanese patients
with COVID-19. BMJ Open Respir Res. 10(1):e001625, 2023 May
Omori M, Minegishi Y, Uruga H, Fukuizumi A, Isobe K, Izumi S, Koyama R, Bando M, Sugiyama H, Takahashi
K, Gemma A, Homma S, Sugiyama Y, Kishi K. Carboplatin and weekly paclitaxel in combination with
bevacizumab for the treatment of advanced non-small cell lung cancer complicated by idiopathic
interstitial pneumonias: A feasibility study. Respir Investig. 61(5): 625-631, 2023 Jun
Haraguchi M, Kiyotani K, Tate T, Sakata S, Sagawa R, Takagi S, Nagayama S, Takeuchi K, Takahashi K,
Katayama R. Spatiotemporal commonality of the TCR repertoire in a T-cell memory murine model and in
metastatic human colorectal cancer. Cancer Immunol Immunother. 72(9):2971-2989, 2023
Shukuya T, Takahashi K, Shintani Y, Miura K, Sekine I, Takayama K, Inoue A, Okamoto I, Kiura K,
Kawaguchi T, Yamamoto N, Miyaoka E, Yoshino I, Date H. Epidemiology, risk factors and impact of cachexia
on patient outcome: Results from the Japanese Lung Cancer Registry Study. J Cachexia Sarcopenia Muscle.
14(3):1274-1285, 2023 Jun
Torasawa M, Yoshida T, Takeyasu Y, Shimoda Y, Tateishi A, Matsumoto Y, Masuda K, Shinno Y, Okuma Y, Goto
Y, Horinouchi H, Yamamoto N, Takahashi K, Ohe Y. Disease progression status during initial immune
checkpoint inhibitor (ICI) affects the clinical outcome of ICI retreatment in advanced non-small cell
lung cancer patients. Cancer Med. 12(11):12388-12401, 2023 Jun
Kojima S, Koyama S, Ka M, Saito Y, Parrish EH, Endo M, Takata S, Mizukoshi M, Hikino K, Takeda A,
Gelinas AF, Heaton SM, Koide R, Kamada AJ, Noguchi M, Hamada M; Biobank Japan Project Consortium;
Kamatani Y, Murakawa Y, Ishigaki K, Nakamura Y, Ito K, Terao C, Momozawa Y, Parrish NF. Mobile element
variation contributes to population-specific genome diversification, gene regulation and disease risk.
Nat Genet. 55(6):939-951, 2023 Jun
Tanaka H, Chubachi S, Namkoong H, Sato Y, Asakura T, Lee H, Azekawa S, Otake S, Nakagawara K, Fukushima
T, Watase M, Sakurai K, Kusumoto T, Kondo Y, Masaki K, Kamata H, Ishii M, Kaneko Y, Hasegawa N, Ueda S,
Sasaki M, Izumo T, Inomata M, Miyazawa N, Kimura Y, Suzuki Y, Harada N, Ichikawa M, Takata T, Ishikura
H, Yoshiyama T, Kokuto H, Murakami K, Sano H, Ueda T, Kuwahara N, Fujiwara A, Ogura T, Inoue T, Asami T,
Mutoh Y, Nakachi I, Baba R, Nishi K, Tani M, Kagyo J, Hashiguchi M, Oguma T, Asano K, Nishikawa M,
Watanabe H, Okada Y, Koike R, Kitagawa Y, Kimura A, Imoto S, Miyano S, Ogawa S, Kanai T, Fukunaga K.
Propensity-Score Matched Analysis of the Effectiveness of Baricitinib in Patients With Coronavirus
Disease 2019 (COVID-19) Using Nationwide Real-World Data: An Observational Matched Cohort Study From the
Japan COVID-19 Task Force. Open Forum Infect Dis. 10(7):ofad311, 2023 Jun
Kato M, Sasaki S, Mori W, Kohmaru M, Akimoto T, Hayakawa E, Soma S, Arai Y, Matsubara NS, Nakazawa S,
Sueyasu T, Hirakawa H, Motomura H, Sumiyoshi I, Ochi Y, Watanabe J, Hoshi K, Kadoya K, Ihara H, Hou J,
Togo S, Takahashi K. Nintedanib administration after the onset of acute exacerbation of interstitial
lung disease in the real world. Sci Rep. 13(1):12528, 2023 Aug
Omori M, Minegishi Y, Uruga H, Fukuizumi A, Isobe K, Izumi S, Koyama R, Bando M, Sugiyama H, Takahashi
K, Gemma A, Homma S, Sugiyama Y, Kishi K. Carboplatin and weekly paclitaxel in combination with
bevacizumab for the treatment of advanced non-small cell lung cancer complicated by idiopathic
interstitial pneumonias: A feasibility study. Respir Investig. 61(5):625-631, 2023 Sep
Haraguchi M, Kiyotani K, Tate T, Sakata S, Sagawa R, Takagi S, Nagayama S, Takeuchi K, Takahashi K,
Katayama R. Spatiotemporal commonality of the TCR repertoire in a T-cell memory murine model and in
metastatic human colorectal cancer. Cancer Immunol Immunother. 72(9):2971-2989, 2023 Sep
Jin B, Oyama R, Tabe Y, Tsuchiya K, Hando T, Wakita M, Yan Y, Saita M, Takei S, Horiuchi Y, Miida T,
Naito T, Takahashi K, Ogawa H. Investigation of the individual genetic evolution of SARS-CoV-2 in a
small cluster during the rapid spread of the BF.5 lineage in Tokyo, Japan. Front Microbiol. 14:1229234,
2023 Sep
Takahashi T, Ai T, Saito K, Nojiri S, Takahashi M, Igawa G, Yamamoto T, Khasawneh A, Paran FJ, Takei S,
Horiuchi Y, Kanno T, Tobiume M, Hiki M, Wakita M, Miida T, Okuzawa A, Suzuki T, Takahashi K, Naito T,
Tabe Y. Assessment of antibody dynamics and neutralizing activity using serological assay after
SARS-CoV-2 infection and vaccination. PLoS One. 18(9):e0291670, 2023 Sep
Kurokawa K, Shukuya T, Greenstein RA, Kaplan BG, Wakelee H, Ross JS, Miura K, Furuta K, Kato S, Suh J,
Sivakumar S, Sokol ES, Carbone DP, Takahashi K. Genomic characterization of thymic epithelial tumors in
a real-world dataset. ESMO Open. 8(5):101627, 2023 Oct
Tsuboshima K, Kurihara M, Okumura G, Ohashi K, Takahashi K, Shiko Y, Ozawa Y, Seyama K. Postoperative
hormonal therapies reduce the recurrence of thoracic endometriosis-related pneumothorax. Eur J
Cardiothorac Surg. 64(4): ezad331, 2023 Oct
Sandhu Y, Harada N, Harada S, Nishimaki T, Sasano H, Tanabe Y, Takeshige T, Matsuno K, Ishimori A,
Katsura Y, Ito J, Akiba H, Takahashi K. MAP3K19 Affects TWEAK-Induced Response in Cultured Bronchial
Epithelial Cells and Regulates Allergic Airway Inflammation in an Asthma Murine Model. Curr Issues Mol
Biol. 45(11):8907-8924, 2023 Nov
Asao T, Shukuya T, Mimori T, Goto Y, Tanaka H, Takayama K, Tsubata Y, Tachihara M, Suzuki T, Kaira K, Ko
R, Zenke Y, Akamatsu H, Tanizaki J, Ikeda S, Sugawara S, Mizutani H, Mori K, Takahashi K. Study Design
and Rationale for Marble Study: A Phase II Trial of Atezolizumab (MPDL3280A) Plus Carboplatin and
Paclitaxel in Patients With Advanced or Recurrent Thymic Carcinoma (JTD2101). Clin Lung Cancer. 24(7):
e247-e253, 2023 Nov
Harada N, Makita N, Fukui K, Nishida K, Oneda K, Tashiro N. A retrospective claims database study to
clarify diseaseburden of severe asthma patients with type 2 high or low inflammation. J Asthma Allergy.
16:83-93, 2023 Jan
Fukui M, Harada N, Takamochi K, Hayashi T, Matsunaga T, Hattori A, Kawagoe I, Suzuki K. The balance
between lung regulatory T cells and Th17 cells is a risk indicator for the acute exacerbation of
interstitial lung disease after surgery: a case-control study. BMC Pulm Med. 23(1):70, 2023 Feb
Nakagawara K, Kamata H, Chubachi S, Namkoong H, Tanaka H, Lee H, Otake S, Fukushima T, Kusumoto T,
Morita A, Azekawa S, Watase M, Asakura T, Masaki K, Ishii M, Endo A, Koike R, Ishikura H, Takata T,
Matsushita Y, Harada N, Kokutou H, Yoshiyama T, Kataoka K, Mutoh Y, Miyawaki M, Ueda S, Ono H, Ono T,
Shoko T, Muranaka H, Kawamura K, Mori N, Mochimaru T, Fukui M, Chihara Y, Nagasaki Y, Okamoto M,
Amishima M, Odani T, Tani M, Nishi K, Shirai Y, Edahiro R, Ando A, Hashimoto N, Ogura S, Kitagawa Y,
Kita T, Kagaya T, Kimura Y, Miyazawa N, Tsuchida T, Fujitani S, Murakami K, Sano H, Sato Y, Tanino Y,
Otsuki R, Mashimo S, Kuramochi M, Hosoda Y, Hasegawa Y, Ueda T, Takaku Y, Ishiguro T, Fujiwara A,
Kuwahara N, Kitamura H, Hagiwara E, Nakamori Y, Saito F, Kono Y, Abe S, Ishii T, Ohba T, Kusaka Y,
Watanabe H, Masuda M, Watanabe H, Kimizuka Y, Kawana A, Kasamatsu Y, Hashimoto S, Okada Y, Takano T,
Katayama K, Ai M, Kumanogoh A, Sato T, Tokunaga K, Imoto S, Kitagawa Y, Kimura A, Miyano S, Hasegawa N,
Ogawa S, Kanai T, Fukunaga K, Japan C-TF. Diagnostic significance of secondary bacteremia in patients
with COVID-19. J Infect Chemother. 29(4):422-426, 2023 Apr
Tomomatsu K, Yasuba H, Ishiguro T, Imokawa S, Hara J, Soeda S, Harada N, Tsurikisawa N, Oda N, Katoh S,
Numata T, Sugino Y, Yamada M, Kamimura M, Terashima T, Okada N, Tanaka J, Oguma T, Asano K. Real-world
efficacy of anti-IL-5 treatment in patients with allergic bronchopulmonary aspergillosis. Sci Rep.
13(1):5468, 2023 Apr
Goto Y, Shukuya T, Murata A, Kikkawa H, Emir B, Wiltshire R, Miura S. Real-world therapeutic
effectiveness of lorlatinib after alectinib in Japanese patients with ALK-positive non-small-cell lung
cancer. Cancer Sci. 114(6):2560-2568, 2023 Jun
"Miyanaga A, Asahina H, Watanabe S, Shukuya T, Tsubata Y, Hosomi Y, Sugawara S, Maemondo M, Okano
T, Morita S, Matsuyama K, Kobayashi K, Seike M. A Phase I/II Study of Necitumumab Plus Pembrolizumab,
Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small Cell Lung Cancer
Study: (NEJ048A/NEXUS). Clin Lung Cancer. 24(4):371-375, 2023 Jun
Ozawa T, Asakura T, Chubachi S, Namkoong H, Tanaka H, Lee K, Fukushima T, Otake S, Nakagawara K, Watase
M, Masaki K, Kamata H, Ishii M, Hasegawa N, Harada N, Ueda T, Ueda S, Ishiguro T, Arimura K, Saito F,
Yoshiyama T, Nakano Y, Mutoh Y, Suzuki Y, Edahiro R, Murakami K, Okada Y, Koike R, Kitagawa Y, Tokunaga
K, Kimura A, Imoto S, Miyano S, Ogawa S, Kanai T, Fukunaga K, Japan C-TF. Use of the
neutrophil-to-lymphocyte ratio and an oxygen requirement to predict disease severity in patients with
COVID-19. Respir Investig. 61(4):454-459, 2023 Jul"
Goto Y, Kawamura K, Fukuhara T, Namba Y, Aoe K, Shukuya T, Tsuda T, Santorelli ML, Taniguchi K, Kamitani
T, Irisawa M, Kanda K, Abe M, Burke T, Nokihara H. Health Care Resource Use Among Patients with Advanced
Non-Small Cell Lung Cancer in Japan, 2017-2019. 99:100712, 2023 Jul
Tanaka H, Maetani T, Chubachi S, Tanabe N, Shiraishi Y, Asakura T, Namkoong H, Shimada T, Azekawa S,
Otake S, Nakagawara K, Fukushima T, Watase M, Terai H, Sasaki M, Ueda S, Kato Y, Harada N, Suzuki S,
Yoshida S, Tateno H, Yamada Y, Jinzaki M, Hirai T, Okada Y, Koike R, Ishii M, Hasegawa N, Kimura A,
Imoto S, Miyano S, Ogawa S, Kanai T, Fukunaga K. Clinical utilization of artificial intelligence-based
COVID-19 pneumonia quantification using chest computed tomography - a multicenter retrospective cohort
study in Japan. Respir Res. 24(1):241, 2023 Oct
Nakamichi S, Kubota K, Matsuyama K, Misumi T, Kozuki T, Sugawara S, Naoki K, Kobayashi N, Shukuya T,
Shimokawa T, Ishihara M, Wakui H, Hosomi Y, Tanaka H, Saito H, Hosokawa S, Takiguchi Y, Kasai T,
Nokihara H, Morita R, Aono H, Furuya N, Okamoto H. A Phase Ⅱ Study of Ubenimex Combined With
Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small-Cell
Lung Cancer: TORG2241 (UBE-Q). Clin Lung Cancer. 4:S1525-7304(23)00186-9, 2023 Oct
Kusumoto T, Chubachi S, Namkoong H, Tanaka H, Lee H, Azekawa S, Otake S, Nakagawara K, Fukushima T,
Morita A, Watase M, Sakurai K, Asakura T, Masaki K, Kamata H, Ishii M, Hasegawa N, Harada N, Ueda T,
Ueda S, Ishiguro T, Arimura K, Saito F, Yoshiyama T, Nakano Y, Mutoh Y, Suzuki Y, Edahiro R, Sano H,
Sato Y, Okada Y, Koike R, Kitagawa Y, Tokunaga K, Kimura A, Imoto S, Miyano S, Ogawa S, Kanai T,
Fukunaga K. Association between ABO blood group/genotype and COVID-19 in a Japanese population. Ann
Hematol. 102(11):3239-3249, 2023 Nov
Terai H, Ishii M, Takemura R, Namkoong H, Shimamoto K, Masaki K, Tanosaki T, Chubachi S, Matsuyama E,
Hayashi R, Shimada T, Shigematsu L, Ito F, Kaji M, Takaoka H, Kurihara M, Nakagawara K, Tomiyasu S,
Sasahara K, Saito A, Otake S, Azekawa S, Okada M, Fukushima T, Morita A, Tanaka H, Sunata K, Asaoka M,
Nishie M, Shinozaki T, Ebisudani T, Akiyama Y, Mitsuishi A, Nakayama S, Ogawa T, Sakurai K, Irie M, Yagi
K, Ohgino K, Miyata J, Kabata H, Ikemura S, Kamata H, Yasuda H, Kawada I, Kimura R, Kondo M, Iwasaki T,
Ishida N, Hiruma G, Miyazaki N, Ishibashi Y, Harada S, Fujita T, Ito D, Bun S, Tabuchi H, Kanzaki S,
Shimizu E, Fukuda K, Yamagami J, Kobayashi K, Hirano T, Inoue T, Haraguchi M, Kagyo J, Shiomi T, Lee H,
Sugihara K, Omori N, Sayama K, Otsuka K, Miyao N, Odani T, Watase M, Mochimaru T, Satomi R, Oyamada Y,
Masuzawa K, Asakura T, Nakayama S, Suzuki Y, Baba R, Okamori S, Arai D, Nakachi I, Kuwahara N, Fujiwara
A, Oakada T, Ishiguro T, Isosno T, Makino Y, Mashimo S, Kaido T, Minematsu N, Ueda S, Minami K, Hagiwara
R, Manabe T, Fukui T, Funatsu Y, Koh H, Yoshiyama T, Kokuto H, Kusumoto T, Oashi A, Miyawaki M, Saito F,
Tani T, Ishioka K, Takahashi S, Nakamura M, Harada N, Sasano H, Goto A, Kusaka Y, Ohba T, Nakano Y,
Nishio K, Nakajima Y, Suzuki S, Yoshida S, Tateno H, Kodama N, Shunsuke M, Sakamoto S, Okamoto M,
Nagasaki Y, Umeda A, Miyagawa K, Shimada H, Hagimura K, Nagashima K, Sato T, Sato Y, Hasegawa N,
Takebayashi T, Nakahara J, Mimura M, Ogawa K, Shimmura S, Negishi K, Tsubota K, Amagai M, Goto R, Ibuka
Y, Kitagawa Y, Kanai T, Fukunaga K. Comprehensive analysis of long COVID in a Japanese nationwide
prospective cohort study. Respir Investig. 61(6):802-814, 2023 Nov
Sunata K, Miyata J, Terai H, Matsuyama E, Watase M, Namkoong H, Asakura T, Masaki K, Chubachi S, Ohgino
K, Kawada I, Harada N, Sasano H, Nakamura A, Kusaka Y, Ohba T, Nakano Y, Nishio K, Nakajima Y, Suzuki S,
Yoshida S, Tateno H, Ishii M, Fukunaga K. Asthma is a risk factor for general fatigue of long COVID in
Japanese nation-wide cohort study. Allergol Int. 22:S1323-8930(23)00115-6, 2023 Nov
Baba T, Kusumoto M, Kato T, Kurihara Y, Sasaki S, Oikado K, Saito Y, Endo M, Fujiwara Y, Kenmotsu H,
Sata M, Takano T, Kato K, Hirata K, Katagiri T, Saito H, Kuwano K. Clinical and imaging features of
interstitial lung disease in cancer patients treated with trastuzumab deruxtecan. Int J Clin Oncol.
28(12):1585-1596, 2023 Dec
英文総説
Matsuda H, Katayama I, Watanabe T, Komatsu A, Iwakami N, Goto Y, Suzuki M, Iwakami S, Takahashi K. Vogesella urethralis-induced aspiration pneumonia and bacteremia in an elderly man: a first case report and literature review. BMC Infect Dis. 23(1): 285, 2023 May
Namba Y, Ebana H, Okamoto S, Kobayashi E, Kurihara M, Sekimoto Y, Tsuboshima K, Okura MK, Mitsuishi Y, Takahashi K, Seyama K. Clinical and genetic features of 334 Asian patients with Birt-Hogg-Dubé syndrome (BHDS) who presented with pulmonary cysts with or without a history of pneumothorax, with special reference to BHDS-associated pneumothorax. PLoS One. 18(7):e0289175, 2023 Jul
英文症例報告
Sakamoto N, Kato M, Oni T, Terayama Y, Nakazawa S, Okamoto S, Ito J, Takahashi K. Pneumatosis intestinalis with free air in the abdominal cavity caused by nintedanib. Respirol Case Rep. 11(3):e01085, 2023 Jan
Sekimoto Y, Kohmaru M, Okuma T, Tajima M, Sekiya M. Subcutaneous and muscle layer seroma complicated with thoracentesis. Respirol Case Rep 11(3): e01100, 2023 Feb
Nishioki T, Koyama R, Okubo H, Fukuo Y, Takasaki Y, Yae T, Banno T, Kido K, Takahashi K, Shiina S, Ikejima K. Endobronchial Watanabe Spigot Placement for Hepatic Abscess and Bronchobiliary Fistula Following Radiofrequency Ablation for Hepatocellular Carcinoma: A Case Report. Intern Med. 62(7): 999-1004, 2023 Apr
Sekimoto Y, Sekiya M, Kohmaru M, Okuma T, Tajima M, Sato H, Takahashi K. Primary pulmonary lymphoma diagnosed by ultrasound-guided transthoracic needle biopsy. Respirol Case Rep. 11(7): e01159, 2023 Jun
Katayama I, Komatsu A, Watanabe T, Hayakawa D, Iwakami N, Genda T, Iwakami S, Takahashi K. Mediastinal pancreatic pseudocyst diagnosed based on black pleural effusion. Respirology Case Rep. 11(8): e01195, 2023 Jul
Akiyama Y, Sonehara K, Maeda D, Katoh H, Naito T, Yamamoto K; Biobank Japan Project; Morisaki T, Ishikawa S, Ushiku T, Kume H, Homma Y, Okada Y. Genome-wide association study identifies risk loci within the major histocompatibility complex region for Hunner-type interstitial cystitis. Cell Rep Med. 4(7):101114, 2023 Jul
Katayama I, Komatsu A, Watanabe T, Hayakawa D, Iwakami N, Genda T, Iwakami SI, Takahashi K. Mediastinal pancreatic pseudocyst diagnosed based on black pleural effusion. Respirol Case Rep. 11(8):e01195, 2023 Jul
2022年
T Mimori, T Shukuya, R Ko, Y Okuma, T Koizumi, H Imai, Y Takiguchi, E Miyauchi, H Kagamu, T Sugiyama, K
Azuma, Y Namba, M Yamasaki, H Tanaka, Y Takashima, S Soda, O Ishimoto, N Koyama, K Kobayashi, K
Takahashi. Clinical Significance of Tumor Markers for
Advanced Thymic Carcinoma: A Retrospective Analysis from the NEJ023 Study. Cancers (Basel)., 2022;
14(2): 331.
MR Woodford, A Andreou, M Baba, I van de Beek, C Di Malta, I Glykofridis, H Grimes, EP Henske, O
Iliopoulos, M Kurihara, R Lazor, WM Linehan, K Matsumoto, SJ Marciniak, Y Namba, A Pause, N Rajan, A
Ray, LS Schmidt, W Shi, OK Steinlein, J Thierauf, R Zoncu,
A Webb, M Mollapour. Seventh BHD international symposium: recent scientific and clinical advancement.
Oncotarget., 2022; 13: 173-181.
H Tad, T Mitsudomi, T Misumi, K Sugio, M Tsuboi, I Okamoto, Y Iwamoto, N Sakakura, S Sugawara, S Atagi,
T Takahashi, H Hayashi, M Okada, H Inokawa, H Yoshioka, K Takahashi, M Higashiyama, I Yoshino, K
Nakagawa; West Japan Oncology Group. Randomized Phase
III Study of Gefitinib Versus Cisplatin Plus Vinorelbine for Patients With Resected Stage II-IIIA
Non-Small-Cell Lung Cancer With EGFR Mutation (IMPACT). J Clin Oncol., 2022; 40(3): 231-241.
A Wirawan, K Tajima, F Takahashi, Y Mitsuishi, W Winardi, M Hidayat, D Hayakawa, N Matsumoto, K Izumi, T
Asao, R Ko, N Shimada, K Takamochi, K Suzuki, M Abe, O Hino, Y Sekido, K Takahashi. A Novel Therapeutic
Strategy Targeting the Mesenchymal Phenotype
of Malignant Pleural Mesothelioma By Suppressing LSD1. Mol Cancer Res., 2022; 20(1): 127-138.
H Nakayama, E Oshima, T Hotta, K Hanafusa, K Nakamura, N Yokoyama, H Ogawa, K Takamori, K Iwabuchi.
Identification of anti-lipoarabinomannan antibodies against mannan core and their effects on
phagocytosis of mycobacteria by human neutrophils. Tuberculosis
(Edinb)., 2022; 132: 102165.
H Jo, T Yoshida, H Horinouchi, S Yagishita, Y Matsumoto, Y Shinno, Y Okum, Y Goto, N Yamamoto, K
Takahashi, N Motoi, Y Ohe. Prognostic significance of cachexia in advanced non-small cell lung cancer
patients treated with pembrolizumab. Cancer Immunol
Immunother., 2022; 71(2):387-398.
N Enomoto, S Homma, N Inase, Y Kondoh, T Saraya, H Takizawa, Y Inoue, H Ishii, Y Taguchi, S Izumi, Y
Yamano, Y Tanino, Y Nishioka, M Toyoshima, K Yokomura, S Imokawa, N Koshimizu, T Sano, T Akamatsu, H
Mukae, M Kato, N Hamada, H Chiba, S Akagawa, S Muro,
H Uruga, H Matsuda, Y Kaida, M Kanai, K Mori, M Masuda, H Hozumi, T Fujisawa, Y Nakamura, N Ogawa, T
Suda. Prospective nationwide multicentre cohort study of the clinical significance of autoimmune
features in idiopathic interstitial pneumonias. Thorax.,
2022; 77(2): 143-153.
N Enomoto, S Homma, N Inase, Y Kondoh, T Saraya, H Takizawa, Y Inoue, H Ishii, Y Taguchi, S Izumi, Y
Yamano, Y Tanino, Y Nishioka, M Toyoshima, K Yokomura, S Imokawa, N Koshimizu, T Sano, T Akamatsu, H
Mukae, M Kato, N Hamada, H Chiba, S Akagawa, S Muro,
Uruga H, Matsuda H, Kaida Y, Kanai M, Mori K, Masuda M, Hozumi H, Fujisawa T, Nakamura Y, Ogawa N, Suda
T. Prospective nationwide multicentre cohort study of the clinical significance of autoimmune features
in idiopathic interstitial pneumonias. Thorax.
2022 Feb;77(2):143-153.
K Enomoto, Y Eguchi, T Sato, M Norimoto, M Inoue, A Watanabe, T Sakai, M Yoneyama, Y Aoki, S Orita, M
Narita, K Inage, Y Shiga, T Umimura, M Sato, M Suzuki, H Takaoka, N Mizuki, G Kim, T Hozumi, N Hirosawa,
T Furuya, S Maki, J Nakamura, S Hagiwara, M
Koda, T Akazawa, H Takahashi, K Takahashi, S Ohtori. Usefulness of Simultaneous Magnetic Resonance
Neurography and Apparent T2 Mapping for the Diagnosis of Cervical Radiculopathy. Asian Spine J., 2022;
16(1): 47-55.
E Miyawaki, H Kenmotsu, Y Shintani, I Sekine, T Shukuya, K Takayama, A Inoue, I Okamoto, K Kiura, K
Takahashi, Yamamoto N, Kawaguchi T, Miyaoka E, Yoshino I, Date H. Efficacy of platinum agents for stage
III non-small-cell lung cancer following platinum-based
chemoradiotherapy: a retrospective study. BMC Cancer., 2022; 22(1): 342.
SS Shimamura, T Shukuya, T Asao, D Hayakawa, K Kurokawa, S Xu, K Miura, Y Mitsuishi, K Tajima, R
Shibayama, N Shimada, F Takahashi, K Takahashi. Survival past five years with advanced, EGFR-mutated or
ALK-rearranged non-small cell lung cancer-is there
a "tail plateau" in the survival curve of these patients? BMC Cancer., 2022; 22(1): 323.
A Harigai, AI Saito, T Inoue, M Suzuki, Y Namba, Y Suzuki, F Makino, O Nagashima, S Sasaki, K Sasai. The
prognostic value of (18)F-FDG PET/CT taken immediately after completion of radiotherapy for lung cancer
treated with concurrent chemoradiotherapy:
A pilot study. Cancer Radiother., 2022; 26: 711-716
S Ueda, J Ito, N Harada, S Harada, H Sasano, Y Sandhu, Y Tanabe, S Abe, S Shiota, Y Kodama, T Nagaoka, F
Makino, A Chiba, H Akiba, R Atsuta, A Miyake, K Takahashi. Effect of Japanese Cedar Pollen Sublingual
Immunotherapy on Asthma Patients with Seasonal
Allergic Rhinitis Caused by Japanese Cedar Pollen. Biomolecules., 2022; 12(4): 518.
S Xu, T Shukuya, J Tamura, S Shimamura, K Kurokawa, K Miura, T Miyawaki, D Hayakawa, T Asao, K Yamamoto,
K Takahashi. Heterogeneous Outcomes of Immune Checkpoint Inhibitor Rechallenge in Patients With NSCLC: A
Systematic Review and Meta-Analysis. JTO
Clin Res Rep., 2022; 3(4): 100309.
K Nakamura, H Nakayama, S Sasaki, K Takahashi, K Iwabuchi. Mycobacterium avium-intracellulare complex
promote release of pro-inflammatory enzymes matrix metalloproteinases by inducing neutrophil
extracellular trap formation. Sci Rep., 2022; 12(1): 5181
Y Yan, T Naito, Y Tabe, K Ito, S Nojiri, GA Deshpande, K Seyama, K Takahashi. Increased delta variant
SARS-CoV-2 infections in a highly vaccinated medical center in Japan. Vaccine., 2022; 40(23): 3103-3108.
NA Nitta, T Sato, M Komura, H Yoshikawa, Y Suzuki, A Mitsui, E Kuwasaki, F Takahashi, Y Kodama, K
Seyama, K Takahashi. Exposure to the heated tobacco product IQOS generates apoptosis-mediated pulmonary
emphysema in murine lungs. Am J Physiol Lung Cell
Mol Physiol., 2022; 322(5): L699-L711.
K Tsuchihashi, Y Hirata, J Yamasaki, K Suina, K Tanoue, T Yae, K Masuda, E Baba, K Akashi, Y Kitagawa, H
Saya, O Nagano. Presence of spontaneous epithelial-mesenchymal plasticity in esophageal cancer. Biochem
Biophys Rep., 2022; 30: 101246.
G Igawa, T Ai, T Yamamoto, K Ito, S Nojiri, K Saito, M Wakita, H Fukuda, S Hori, S Misawa, T Miida, K
Seyama, K Takahashi, Y Tabe, T Naito. Antibody response and seroprevalence in healthcare workers after
the BNT162b2 vaccination in a University Hospital
at Tokyo. Sci Rep., 2022; 12(1): 8707.
Y Nanjo, T Okuma, Y Kuroda, E Hayakawa, K Shibayama, T Akimoto, R Murashima, K Kanamori, T Tsutsumi, Y
Suzuki, Y Namba, F Makino, O Nagashima, S Sasaki, K Takahashi. Multiple Types of Taste Disorders among
Patients with COVID-19. Intern Med. , 2022; ;61(14):
2127-2134.
M Torasawa, T Yoshida, S Yagishita, Y Shimoda, M Shirasawa, Y Matsumoto, K Masuda, Y Shinno, Y Okuma, Y
Goto, H Horinouchi, N Yamamoto, K Takahashi, Y Ohe. Nivolumab versus pembrolizumab in previously-treated
advanced non-small cell lung cancer patients:
A propensity-matched real-world analysis. Lung Cancer., 2022; 167: 49-57.
K Tsuchiya, Y Hosaka, T Takahashi, M Chonan, Y Makita, I Katayama, T Ai, M Idei, Y Horiuchi, K Yamatani,
M Wakita, S Misawa, A Okuzawa, T Miida, T Naito, K Takahashi, Y Tabe. Meals and Room Temperature Storage
do not Significantly Affect Feasibility of
Direct RT-PCR Tests for SARS-CoV-2 Using Saliva. Clin Lab., 2022; 68(6).
doi:10.7754/Clin.Lab.2021.210451.
T Miyawaki, T Naito, K Doshita, H Kodama, M Mori, N Nishioka, Y Iida, E Miyawaki, N Mamesaya, H
Kobayashi, S Omori, R Ko, K Wakuda, A Ono, H Kenmotsu, H Murakami, K Mori, H Harada, M Endo, K
Takahashi, T Takahashi. Predicting the efficacy of first-line
immunotherapy by combining cancer cachexia and tumor burden in advanced non-small cell lung cancer.
Thorac Cancer., 2022; 13(14): 2064-2074.
T Yoshida, T Nagaoka, Y Nagata, Y Suzuki, T Tsutsumi, S Kuriyama, J Watanabe, S Togo, F Takahashi, M
Matsushita, Y Joki, H Konishi, S Nunomura, K Izuhara, SJ Conway, K Takahashi. Periostin-related
progression of different types of experim;ental pulmonary
hypertension: A role for M2 macrophage and FGF-2 signalling. Respirology.; 2022; 27(7): 529-538.
H Namkoong, K Takahashi, Y Okada, et al. DOCK2 is involved in the host genetics and biology of severe
COVID-19. Nature., 2022; 609(7928): 754-760.
C Iwamura, K Hirahara, M Kiuchi, S Ikehara, K Azuma, T Shimada, S Kuriyama, S Ohki, E Yamamoto, Y Inaba,
Y Shiko, A Aoki, K Kokubo, R Hirasawa, T Hishiya, K Tsuji, T Nagaoka, S Ishikawa, A Kojima, H Mito, R
Hase, Y Kasahara, N Kuriyama, T Tsukamoto, S
Nakamura, T Urushibara, S Kaneda, S Sakao, M Tobiume, Y Suzuki, M Tsujiwaki, T Kubo, T Hasegawa, H
Nakase, O Nishida, K Takahashi, K Baba, Y Iizumi, T Okazaki, MY Kimura, I Yoshino, H Igari, H Nakajima,
T Suzuki, H Hanaoka, TA Nakada, Y Ikehara, K Yokote,
T Nakayama. Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2-induced lung exudative
vasculitis and predicts COVID-19 severity. Proc Natl Acad Sci U S A., 2022; 119(33): e2203437
SQ Wang, K Takahashi, Y Okada, et al. The whole blood transcriptional regulation landscape in 465
COVID-19 infected samples from Japan COVID-19 Task Force. Nat Commun., 2022; 13(1): 4830.
M Komura, T Sato, H Yoshikawa, N Arano Nitta, Y Suzuki, K Koike, Y Kodama, K Seyama, K Takahashi.
Propylene glycol, a component of electronic cigarette liquid, damages epithelial cells in human small
airways. Respir Res., 2022; 23(1): 216.
M Takahashi, T Ai, K Sinozuka, Y Baba, G Igawa, S Nojiri, T Yamamoto, M Yuri, S Takei, K Sait, Y
Horiuchi, T Kanno, M Tobiume, A Khasawneh, FJ Paran, M Hiki, M Wakita, T Miida, T Suzuki, A Okuzawa, K
Takahashi, T Naito, Y Tabe. Activation of SARS-CoV-2
neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG
antibodies. Scientific reports., 2022; 12(1): 14909.
B Heissig, Y Salama, R Iakoubov R, Vehreschil JJ, Rios R, Nogueira T, Vehreschild MJGT, Stecher M, Mori
H, Lanznaster J, Adachi E, Jakob C, Tabe Y, Ruethrich M, Borgmann S, Naito T, Wille K, Valenti S, Hower
M, Hattori N, Rieg S, Nagaoka T, Jensen BE,
Yotsuyanagi H, Hertenstein B, Ogawa H, Wyen C, Kominami E, Roemmele C, Takahashi S, Rupp J, Takahashi K,
Hanses F, Hattori K. COVID-19 Severity and Thrombo-Inflammatory Response Linked to Ethnicity.
Biomedicine., 2022; 10(10) :2549.
K Kurokawa, Y Mitsuishi, N Shimada, Y Kawakami, K Miura, T Miyawaki, T Asao, R Ko, T Shukuya, R
Shibayama, S Nojiri, K Takahashi. Association between the efficacy and immune-related adverse events of
pembrolizumab and chemotherapy in non-small cell lung
cancer patients: a retrospective study. BMC Cancer., 2022; 22(1): 1047.
K Takamochi K, K Hara, T Hayashi, S Kohsaka, F Takahashi, Y Suehara, M Shimokawa, K Suzuki. Clinical
relevance of PD-L2 expression in surgically resected lung adenocarcinoma. Lung Cancer., 2022; 168:
50-58.
S Kishikawa, T Hayashi, T Saito, K Takamochi, K Sasa, Y Suehara, F Takahashi, N Sasahara, S Kohsaka, K
Suzuki, T Yao. Distinct properties of pure and mixed-type high-grade fetal lung adenocarcinomas by
genetic profiling and transcription factor expression.
Virchows Archiv., 2022; 480(3): 609-619.
S Otake, S Chubachi, H Namkoong, K Nakagawara, H Tanaka, H Lee, A Morita, T Fukushima, M Watase, T
Kusumoto, K Masaki, H Kamata, M Ishii, N Hasegawa, N Harada, T Ueda, S Ueda, T Ishiguro, K Arimura, F
Saito, T Yoshiyama, Y Nakano, Y Mutoh, Y Suzuki, K
Murakami, Y Okada, R Koike, Y Kitagawa, A Kimura, S Imoto, S Miyano, S Ogawa, T Kanai, K Fukunaga, Japan
C-TF. Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan
COVID-19 Task Force, a nation-wide consortium
to investigate COVID-19 host genetics. BMC Infect Dis., 2022; 22(1): 735.
R Hatano, T Itoh, H Otsuka, H Saeki, A Yamamoto, D Song, Y Shirakawa, S Iyama, T Sato, N Iwao, N Harada,
TM Aune, NH Dang, Y Kaneko, T Yamada, C Morimoto, K Ohnuma. Humanized anti-IL-26 monoclonal antibody as
a novel targeted therapy for chronic graft-versus-host.
Am J Transplant., 2022; 22(12): 2804-2820.
H Lee, S Chubachi, H Namkoong, H Tanaka, S Otake, K Nakagawara, A Morita, T Fukushima, M Watase, T
Kusumoto, K Masaki, H Kamata, M Ishii, N Hasegawa, N Harada, T Ueda, S Ueda, T Ishiguro, K Arimura, F
Saito, T Yoshiyama, Y Nakano, Y Mutoh, Y Suzuki, K
Murakami, Y Okada, R Koike, Y Kitagawa, A Kimura, S Imoto, S Miyano, S Ogawa, T Kanai, K Fukunaga, Japan
C-TF. Effects of mild obesity on outcomes in Japanese patients with COVID-19: a nationwide consortium to
investigate COVID-19 host genetics. Nutr
Diabetes., 2022; 12(1): 38.
T Fukushima, S Chubachi, H Namkoong, S Otake, K Nakagawara, H Tanaka, H Lee, A Morita, M Watase, T
Kusumoto, K Masaki, H Kamata, M Ishii, N Hasegawa, N Harada, T Ueda, S Ueda, T Ishiguro, K Arimura, F
Saito, T Yoshiyam, Y Nakano, Y Mutoh, Y Suzuki, K
Murakami, Y Okada, R Koike, Y Kitagawa, A Kimura, S Imoto, S Miyano, S Ogawa, T Kanai, K Fukunaga, Japan
C-TF. U-shaped association between abnormal serum uric acid levels and COVID-19 severity: reports from
the Japan COVID-19 Task Force. Int J Infect
Dis. 2022;122:747-54.
LP McGarvey, SS Birring, AH Morice, PV Dicpinigaitis, ID Pavord, J Schelfhout, AM Nguyen, Q Li, A
Tzontcheva, B Iskold, SA Green, C Rosa, DR Muccino, JA Smith, COUGH-1 and COUGH-2 Investigators
including(Harada N). Efficacy and safety of gefapixant, a
P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and
COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials.
Lancet., 2022; 399(10328): 909-23.
S Oizumi, K Takamura, T Harada, M Tachihara, N Morikawa, R Honda, S Watanabe, T Asao, M Kunisaki, T
Fukuhara, R Noro, E Kikuchi, Y Tsutani, T Tenma, K Kobayashi, H Dosaka-Akita; North East Japan Study
Group, Hokkaido Lung Cancer Clinical Study Group.
Phase II study of carboplatin-paclitaxel alone or with bevacizumab in advanced sarcomatoid carcinoma of
the lung: HOT1201/NEJ024. Int J Clin Oncol., 2022; 27(4): 676-683.
T Asao, S Wtanabe, T Tanaka, S Morita, K Kobayashi. A phase II study of carboplatin and etoposide plus
durvalumab for previously untreated extensive-stage small-cell lung cancer (ES-SCLC) patients with a
poor performance status (PS): NEJ045A study protocol.
BMC Cancer., 2022; 22: 1135.H
H Terai, K Soejima, A Shimokawa, H Horinouchi, J Shimizu, T Hase, R Kanemaru, K Watanabe, K Ninomiya, N
Aragane, N Yanagitani, Y Sakata, M Seike, D Fujimoto, M Kasajima, A Kubo, S Kusumoto, Y Oyamada, K
Fujiwara, M Mori, M Hashimoto, M Shingyoji, M Kodani,
J Sakamoto, T Agatsuma, K Kashiwabara, M Inomata, M Tachihara, K Tanaka, K Hayashihara, N Koyama, K
Matsui, K Minato, D Jingu, H Sakashita, S Hara, T Naito, A Okada, M Tanahashi, Y Sato, K Asano, T
Takeda, K Nakazawa, T Harada, K Shibata, T Kato, E Miyaoka,
I Yoshino, A Gemma, T Mitsudomi. Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using
Japanese Postmarketing All-Case Surveillance Data. JTO Clin Res Rep., 2022; 3(11): 100404
A Yoshimura, T Yamada, M Serizawa, H Uehara, K Tanimura, Y Okuma, A Fukuda, S Watanabe, N Nishioka, T
Takeda, Y Chihara, S Takemoto, T Harada, O Hiranuma, Y Shirai, T Shukuya, A Nishiyama, Y Goto, S
Shiotsu, K Kunimasa, K Morimoto, Y Katayama, K Suda,
T Mitsudomi, S Yano, H Kenmotsu, T Takahashi, K Takayama. High levels of AXL expression in untreated
EGFR-mutated non-small cell lung cancer negatively impacts the use of osimertinib. Cancer Sci., 2023;
114(2):606-618.
Y Nishioka, Y Toyoda, R Egashira, T Johkoh, Y Terasaki, A Hebisawa, K Abe, T Baba, Y Fujikura, E Fujita,
N Hamada, T Handa, Y Hasegawa, K Hidaka, T Hisada, S Hisata, C Honjo, K Ichikado, Y Inoue, S Izumi, M
Kato, T Kishimoto, M Okamoto, K Miki, M Mineshita,
Y Nakamura, S Sakamoto, M Sano, Y Tsukada, M Yamasue, Y Bando, S Homma, K Hagiwara, T Suda, N Inase.
Nationwide retrospective observational study of idiopathic dendriform pulmonary ossification: clinical
features with a progressive phenotype. BMJ Open
Respir Res., 2022; 9(1): e001337
LTH Nguyen, J Zhang, XY Rima, X Wang, KJ Kwak, T Okimoto, J Amann, MJ Yoon, T Shukuya, CL Chiang, N
Walters, Y Ma, D Belcher, H Li, AF Palmer, DP Carbone, LJ Lee, E Reátegui. An immunogold single
extracellular vesicular RNA and protein (Au SERP) biochip
to predict responses to immunotherapy in non-small cell lung cancer patients. J Extracell Vesicles.,
2022; 11(9): e12258.
K Hotta, T Hida, H Nokihara, M Morise, YH Kim, K Azuma, T Seto, Y Takiguchi, M Nishio, H Yoshioka, T
Kumagai, S Watanabe, K Goto, M Satouchi, T Kozuki, T Shukuya,K Nakagawa, T Mitsudomi, N Yamamoto, T
Asakawa, T Yoshimoto, S Takata, T Tamura. Final overall
survival analysis from the phase III J-ALEX study of alectinib versus crizotinib in ALK
inhibitor-naïve Japanese patients with ALK-positive non-small-cell lung cancer. ESMO Open., 2022;
7(4): 100527.
C Zhang, C Wang, Z Yang, Y Bai, T Shukuya, ME Poh, S Ekman, J Li, Y Xu, S Deng. Identification of GPX4
as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance. Transl Lung Cancer Res.,
2022; 11(5): 786-801.
H Kenmotsu, K Wakuda, K Mori, T Kato, S Sugawara, K Kirita, Y Yoneshima, K Azuma, K Nishino, S Teraoka,
T Shukuya, K Masuda, H Hayashi, R Toyozawa, S Miura, D Fujimoto, K Nakagawa, N Yamamoto, T Takahashi.
Randomized Phase 2 Study of Osimertinib Plus
Bevacizumab Versus Osimertinib for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations:
WJOG9717L Study. J Thorac Oncol., 2022; 17(9): 1098-1108.
T Shukuya, K Takamochi, H Sakurai, K Yoh, T Hishida, M Tsuboi, Y Goto, Y Kudo, Y Ohde, S Okumura, M
Taguri, H Kunitoh. Efficacy of Adjuvant Chemotherapy With Tegafur-Uracil in Patients With Completely
Resected, Node-Negative NSCLC-Real-World Data in the
Era of Molecularly Targeted Agents and Immunotherapy. JTO Clin Res Rep., 2022; 3(5):100320.
K Nakagawara, S Chubachi, H Namkoong, H Tanaka, H Lee, S Azekawa, S Otake, T Fukushima, A Morita, M
Watase, K Sakurai, T Kusumoto, T Asakura, K Masaki, H Kamata, M Ishii, N Hasegawa, N Harada, T Ueda, S
Ueda, T Ishiguro, K Arimura, F Saito, T Yoshiyama,
Y Nakano, Y Mutoh, Y Suzuki, R Edahiro, K Murakami, Y Sato, Y Okada, R Koike, Y Kitagawa, K Tokunaga, A
Kimura, S Imoto, S Miyano, S Ogawa, T Kanai, K Fukunaga. Impact of upper and lower respiratory symptoms
on COVID-19 outcomes: a multicenter retrospective
cohort study. Respir Res., 2022; 23(1): 315.
Y Ozawa, N Yamamoto, K Yamamoto, K Ito, H Kenmotsu, H Hayashi, T Shukuya, D Fujimoto, S Sugawara, S
Niho, Y Ohe, H Okamoto, K Nakagawa, K Kiura, I Yoshino, A Gemma. Creation of an Integrated Clinical
Trial Database and Data Sharing for Conducting New
Research by the Japan Lung Cancer Society. JTO Clin Res Rep., 2022; 3(5): 100317.
H Toei, X Zhang, K Seyama, D Yashiro, Y Kuwatsuru, R Kuwatsuru. Prophylactic renal artery embolization
before pregnancy in patients with lymphangioleiomyomatosis and renal angiomyolipoma. J Int Med Res.,
2022; 50(9): 3000605221123897.
K Seyama, M Suzuki, S Tasaka, T Nukiwa, T Sato, S Konno, S Sorrells, J Chen, ME Aragonés, H
Minamino. Long-term safety of Prolastin®-C, an alpha1-proteinase inhibitor, in Japanese patients
with alpha1-antitrypsin deficiency. Respir Investig., 2022; 60:
831-839.
C Inoue, Y Miki, Saito-Koyama R, Kobayashi K, Seyama K, Okada Y, Sasano H. Vasohibin-1 and -2 in
pulmonary lymphangioleiomyomatosis (LAM) cells associated with angiogenic and prognostic factors. Pathol
Res Pract., 2022;230:153758.
H Lee, S Chubachi, H Namkoong, T Asakura, H Tanaka, S Otake, K Nakagawara, A Morita, T Fukushima, M
Watase, T Kusumoto, K Masaki, H Kamata, M Ishii, N Hasegawa, N Harada, T Ueda, S Ueda, T Ishiguro, K
Arimura, F Saito, T Yoshiyama, Y Nakano, Y Mutoh,
Y Suzuki, K Murakami, Y Okada, R Koike, Y Kitagawa, A Kimura, S Imoto, S Miyano, S Ogawa, T Kanai, K
Fukunaga K; Japan COVID-19 Task Force. Characteristics of hospitalized patients with COVID-19 during the
first to fifth waves of infection: a report from
the Japan COVID-19 Task Force. BMC Infect Dis., 2022; 22(1): 935.
M Saita, Y Yan, K Ito, H Sasano, K Seyama, T Naito. Reactogenicity following two doses of the BNT162b2
mRNA COVID-19 vaccine: Real-world evidence from healthcare workers in Japan. J Infect Chemother., 2022;
28:116-119.
N Nomura, H Matsumoto, A Yokoyama, Y Nishimura, K Asano, A Niimi, Y Tohda, N Harada, H Nagase, M Nagata,
H Inoue, M Kondo, T Horiguchi, N Miyahara, N Hizawa, M Hojo, N Hattori, N Hashimoto, A Yamasaki, T
Kadowaki, T Kimura, M Miki, H Taniguchi, M Toyoshima,
T Kawamura, O Matsuno, Y Sato, H Sunadome, T Nagasaki, T Oguma, T Hirai; BEXAS study. Nationwide survey
of refractory asthma with bronchiectasis by inflammatory subtypes. Respir Res., 2022; 23(1): 365.
2021年
Ko R, Shukuya T, Imamura C, Tokito T, Shimada N, Koyama R, Yamada K, Ishii H, Azuma K, Takahashi K. Phase I
study of afatinib plus bevacizumab in patients with advanced non-squamous non-small cell lung cancer harboring
EGFR mutations. Transl Lung Cancer
Res., 2021;10(1): 183-192.
Miyawaki T, Wakuda K, Kenmotsu H, Miyawaki E, Mamesaya N, Kobayashi H, Omori S, Ono A, Naito T, Murakami H,
Notsu A, Mori K, Harada H, Endo M, Ohde Y, Takahashi K, Takahashi T. Proposing Synchronous Oligometastatic
Non-Small Cell Lung Cancer Based on
Progression after First-line Systemic Therapy. Cancer Sci., 2021;112(1): 359-368.
Kato M, Sasaki S, Tateyama M, Arai Y, Motomura H, Sumiyoshi I, Ochi Y, Watanabe J, Ihara H, Togo S, Takahashi K.
Clinical Significance of Continuable Treatment with Nintedanib Over 12 Months for Idiopathic Pulmonary Fibrosis
in a Real-World Setting. Drug
Design, Development and Therapy., 2021; 15: 223-230.
Miyashita Y, Ko R, Shimada N, Mitsuishi Y, Miura K, Matsumoto N, Asao T, Shukuya T, Shibayama R, Koyama R,
Takahashi K. Impact of the generation of EGFR-TKIs administered as priortherapy on the effcacy of osimertinib in
patients with non-small cell lung
cancer harboring EGFR T790M mutation. Thoracic Cancer. 2021;12: 329-338.
Wakita M, Idei M, Saito K, Horiuchi Y, Yamatani K, Ishikawa S, Yamamoto T, Igawa G, Hinata M, Kadota K, Kurosawa
T, Takahashi S, Saito T, Misawa S, Akazawa C, Naito T, Miida T, Takahashi K, Ai T, Tabe Y. Comparison of the
clinical performance and usefulness
of five SARS-CoV-2 antibody tests. PLoS One. 2021;16(2): e0246536.
Sumiyoshi I, Okabe T, Togo S, Takagi H, Motomura H, Ochi Y, Shimada N, Haraguchi M, Shibayama R, Fujimoto Y,
Watanabe J, Iwai M, Kadoya K, Iwakami SI, Takahashi K. High lymphocyte population-related predictive factors for
a long-term response in non-small
cell lung cancer patients treated with pemetrexed: a retrospective observational study. J Transl Med., 2021;
19(1): 92.
Asahina H, Tanaka K, Morita S, Maemondo M, Seike M, Okamoto I, Oizumi S, Kagamu H, Takahashi K, Kikuchi T, Isobe
T, Sugio K, Kobayashi K. A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With
EGFR-Mutated Advanced Non-Small-cell
Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801). Clin Lung Cancer., 2021; 22(2): 147-151.
Sekimoto Y, Suzuki K, Okura M, Hayashi T, Ebana H, Kumasaka T, Mitani K, Nishino K, Okamoto S, Kobayashi E,
Takahashi K, Seyama K. Uncommon radiologic computed tomography appearances of the chest in patients with
lymphangioleiomyomatosis. Sci Rep., 2021;11(1):
7170.
Hiki M, Tabe Y, Ai T, Matsue Y, Harada N, Sugimoto K, Matsushita Y, Matsushita M, Wakita M, Misawa S, Idei M,
Miida T, Tamura N, Takahashi K. Naito T. Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19
patients. PLoS One., 2021;16(4): e0249449.
Udagawa H, Sugiyama E, Harada T, Atagi S, Koyama R, Watanabe S, Nakamura Y, Harada D, Hataji O, Tanaka F, Kida
H, Satouchi M, Maeno K, Inoue A, Yoh K, Yamane Y, Urata Y, Yoshioka H, Yanaka T, Goto K. Bevacizumab plus
platinum-based chemotherapy in advanced
non-squamous non-small-cell lung cancer: a randomized, open-label phase 2 study (CLEAR) Transl Lung Cancer Res.
2021;10(7): 3059-3070.
Nishino K, Yoshimatsu Y, Muramatsu T, Sekimoto Y, Mitani K, Kobayashi E, Okamoto S, Ebana H, Okada Y, Kurihara
M, Suzuki K, Inazawa J, Takahashi K, Watabe T, Seyama K. Isolation and characterisation of lymphatic endothelial
cells from lung tissues affected
by lymphangioleiomyomatosis. Sci Rep., 2021;11(1): 8406.
Nakamura IT, Ikegami M, Hasegawa N, Hayashi T, Ueno T, Kawazu M, Yagishita S, Goto Y, i Shinno Y, Kojima Y,
Takamochi, Takahashi F, Takahashi K, Mano H, Kohsaka S. Development of an optimal protocol for molecular
profiling of tumor cells in pleural effusions
at single-cell level. Cancer Sci., 2021;112(5): 2006-2019.
Iwai M, Tulafu M, Togo S, Kawaji H, Kadoya K, Namba Y, Jin J, Watanabe J, Okabe T, Hidayat M, Sumiyoshi I, Itoh
M, Koyama R, Ito Y, Orimo A, Takamochi K, Oh S, Suzuki K, Hayashizaki Y, Yoshida K, Takahashi K.
Cancer-associated fibroblast migration in
non-small cell lung cancers is modulated by increased integrin α11 expression. Mol Oncol., 2021;15(5):
1507-1527.
Tajima M, Togo S, Ko R, Koinuma Y, Sumiyoshi I, Torasawa M, Kikuchi N, Shiraishi A, Sasaki S, Kyogoku S,
Kuwatsuru R, Takahashi K. CT Guided Needle Biopsy of Peripheral Lesions-Lesion Characteristics That May Increase
the Diagnostic Yield and Reduce the
Complication Rate. J Clin Med., 2021;10(9): 2031.
Okamoto S, Ebana H, Kurihara M, Mitani K, Kobayashi E, Hayashi T, Sekimoto Y, Nishino K, Otsuji M, Kumasaka T,
Takahashi K, Seyama K. Folliculin haploinsufficiency causes cellular dysfunction of pleural mesothelial cells.
Sci Rep., 2021;11(1): 10814.
Nurwidya F, Takahashi F, Winardi W, Tajima K, Mitsuishi Y, Murakami A, Kobayashi I, Nara T, Hashimoto M, Kato M,
Hidayat M, Suina K, Hayakawa D, Asao T, Ko R, Shukuya T, Yae T, Shimada N, Yoshioka Y, Sasaki S, Takahashi K.
Zinc-finger E-box-binding homeobox
1 (ZEB1) plays a crucial role in the maintenance of lung cancer stem cells resistant to gefitinib. Thorac
Cancer., 2021;12(10): 1536-1548.
Sugiyama A, Shiota S, Yanagihara M, Nakayama H, Tsuiki S, Hayashida K, Inoue Y, Takahashi K. The role of
long-term continuous positive airway pressure in the progression of obstructive sleep apnoea: A longitudinal
cohort study. J Sleep Res., 2021;16:
e13374.
Takeshige T, Harada N, Harada S, Ishimori A, Katsura Y, Sasano H, Sandhu Y, Matsuno K, Makino F, Ito J, Atsuta
R, Akiba H, Takahashi K. Chitin induces steroid-resistant airway inflammation and airway hyperresponsiveness in
mice. Allergol Int., 2021;70(3):
343-350.
Nakamura Takeda I, Kohsaka S, Ikegami M, Ikeuchi H, Ueno T, Li K, Beyett TS, Koyama T, Shimizu T, Yamamoto N,
Takahashi F, Takahashi K, Eck MJ, Mano H. Comprehensive functional evaluation of variants of fibroblast growth
factor receptor genes in cancer.
NPJ Precis Oncol., 2021;5(1): 66.
Ohara K, Kinoshita S, Ando J, Azusawa Y, Ishii M, Harada S, Mitsuishi Y, Asao T, Tajima K, Yamamoto T, Takahashi
F, Komatsu N, Takahashi K, Ando M. SCLC-J1, a novel small cell lung cancer cell line. Biochem Biophys Rep.,
2021;27: 101089.
Fukuda H, Seyama K, Ito K, Ai T, Nojiri S, Hori S, Wakita M, Saito K, Shida Y, Nagura R, Hasegawa M, Kanemoto C,
Tokuhara M, Okajima K, Yoshikawa Y, Katsuta N, Yamamoto T, Idei M, Horiuchi Y, Yamatani K, Misawa S, Naito T,
Miida T, Sato H, Hattori N,
Tabe Y, Takahashi K. Author Correction: SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital
in Tokyo. Sci Rep., 2021;11(1): 16042.
Matsushita Y, Kusaoi M, Hiki M, Murayama G, Abe Y, Nozawa K, Takahashi K, Yamaji K, Tamura N, Naito T.
Combination therapy with plasma exchange and glucocorticoid may be effective for severe COVID-19 infection: A
retrospective observational study. Ther
Apher Dial., 2021;25(4): 390-400.
Sakaue S, Kanai M, Tanigawa Y, Karjalainen J, Kurki M, Koshiba S, Narita A, Konuma T, Yamamoto K, Akiyama M,
Ishigaki K, Suzuki A, Suzuki K, Obara W, Yamaji K, Takahashi K, Asai S, Takahashi Y, Suzuki T, Shinozaki N,
Yamaguchi H, Minami S, Murayama S,
Yoshimori K, Nagayama S, Obata D, Higashiyama M, Masumoto A, Koretsune Y; FinnGen, Ito K, Terao C, Yamauchi T,
Komuro I, Kadowaki T, Tamiya G, Yamamoto M, Nakamura Y, Kubo M, Murakami Y, Yamamoto K, Kamatani Y, Palotie A,
Rivas MA, Daly MJ, Matsuda K,
Okada Y. A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet., 2021;53(10):
1415-1424.
Hasegawa N, Kohsaka S, Kurokawa K, Shinno Y, Nakamura IT, Ueno T, Kojima S, Kawazu M, Suehara Y, Ishijima M,
Goto Y, Kojima Y, Yonemori K, Hayashi T, Saito T, Shukuya T, Takahashi F, Takahashi K, Mano H. Highly sensitive
fusion detection using plasma
cell-free RNA in non-small-cell lung cancers. Cancer Sci., 2021;112(10): 4393-4403.
Miyawaki T, Kenmotsu H, Yabe M, Kodama H, Nishioka N, Miyawaki E, Mamesaya N, Kobayashi H, Omori S, Wakuda K,
Ono A, Deguchi S, Mitsuya K, Naito T, Murakami H, Mori K, Harada H, Hayashi N, Takahashi K, Takahashi T.
Rechallenge with previously administered
epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer with
leptomeningeal metastasis. Invest New Drugs 2021;39(6): 1732-1741.
Miyawaki T, Kenmotsu H, Kodama H, Nishioka N, Miyawaki E, Mamesaya N, Kobayashi H, Omori S, Ko R, Wakuda K, Ono
A, Naito T, Murakami H, Mori K, Harada H, Endo M, Takahashi K, Takahashi T. Association between oligo-residual
disease and patterns of failure
during EGFR-TKI treatment in EGFR-mutated non-small cell lung cancer: a retrospective study. BMC Cancer.,
2021;21(1): 1247.
Saito K, Ai T, Kawai A, Matsui J, Fukushima Y, Kikukawa N, Kyoutou T, Chonan M, Kawakami T, Hosaka Y, Misawa S,
Takagi H, Matsushita Y, Hiki M, Okuzawa A, Hori S, Naito T, Miida T, Takahashi K, Tabe Y. Performance and
usefulness of a novel automated immunoassay
HISCL SARS-CoV-2 Antigen assay kit for the diagnosis of COVID-19. Sci Rep., 2021;11(1): 23196.
Katsuta N, Ito K, Fukuda H, Seyama K, Hori S, Shida Y, Nagura R, Nojiri S, Sato H. Elevated depressive symptoms
among newer and younger healthcare workers in Japan during the COVID-19 pandemic. Neuropsychopharmacol Rep. 2021
Dec;41(4):544-547.
Takamochi K, Hara K, Hayashi T, Kohsaka S, Takahashi F, Suehara Y, Suzuki K. Programmed death-ligand 1
expression and its associations with clinicopathological features, prognosis, and driver oncogene alterations in
surgically resected lung adenocarcinoma.
Lung Cancer., 2021;61: 163-170.
Sano K, Hayashi T, Suehara Y, Hosoya M, Takamochi K, Kohsaka S, Kishikawa S, Kishi M, Saito S, Takahashi F,
Kaneko K, Suzuki K, Yao T, Ishijima M, Saito T. Transcription start site-level expression of thyroid
transcription factor 1 isoforms in lung adenocarcinoma
and its clinicopathological significance. Journal of Pathology: Clinical Research., 2021;7(4): 361-374.
Hayashi T, Kohsaka S, Takamochi K, Kishikawa S, Sano K, Hara K, Suehara Y, Takahashi F, Saito T, Suzuki K, Yao
T. Histological Characteristics of Lung Adenocarcinoma With Uncommon Actionable Alterations: Special Emphasis on
MET exon 14 Skipping Alterations.
Histopathology., 2021;78(7): 987-999.
Kishikawa S, Hayashi T, Saito T, Takamochi K, Kohsaka S, Sano K, Sasahara N, Sasa K, Kurihara T, Hara K, Suehara
Y, Takahashi F, Suzuki K, Yao T. Diffuse expression of MUC6 defines a distinct clinicopathological subset of
pulmonary invasive mucinous adenocarcinoma.
Modern Pathology., 2021;34(4):786-797.
Nakagawara K, Namkoong H, Terai H, Masaki K, Tanosaki T, Shimamoto K, Lee H, Tanaka H, Okamori S, Kabata H,
Chubachi S, Ikemura S, Kamata H, Yasuda H, Kawada I, Ishii M, Ishibashi Y, Harada S, Fujita T, Ito D, Bun S,
Tabuchi H, Kanzaki S, Shimizu E, Fukuda
K, Yamagami J, Kobayashi K, Hirano T, Inoue T, Kagyo J, Shiomi T, Ohgino K, Sayama K, Otsuka K, Miyao N, Odani
T, Oyamada Y, Masuzawa K, Nakayama S, Suzuki Y, Baba R, Nakachi I, Kuwahara N, Ishiguro T, Mashimo S, Minematsu
N, Ueda S, Manabe T, Funatsu
Y, Koh H, Yoshiyama T, Saito F, Ishioka K, Takahashi S, Nakamura M, Goto A, Harada N, Kusaka Y, Nakano Y, Nishio
K, Tateno H, Edahiro R, Takeda Y, Kumanogoh A, Kodama N, Okamoto M, Umeda A, Hagimura K, Sato T, Miyazaki N,
Takemura R, Sato Y, Takebayashi
T, Nakahara J, Mimura M, Ogawa K, Shimmura S, Negishi K, Tsubota K, Amagai M, Goto R, Ibuka Y, Hasegawa N,
Kitagawa Y, Kanai T, Fukunaga K. Comprehensive and long-term surveys of COVID-19 sequelae in Japan, an
ambidirectional multicentre cohort study:
study protocol. BMJ Open Respir Res., 2021;8(1): e001015.
Tanaka H, Lee H, Morita A, Namkoong H, Chubachi S, Kabata H, Kamata H, Ishii M, Hasegawa N, Harada N, Ueda T,
Ueda S, Ishiguro T, Arimura K, Saito F, Yoshiyama T, Nakano Y, Mutoh Y, Suzuki Y, Murakami K, Okada Y, Koike R,
Kitagawa Y, Tokunaga K, Kimura
A, Imoto S, Miyano S, Ogawa S, Kanai T, Fukunaga K, Japan C-TF. Clinical Characteristics of Patients with
Coronavirus Disease (COVID-19): Preliminary Baseline Report of Japan COVID-19 Task Force, a Nationwide
Consortium to Investigate Host Genetics of
COVID-19. Int J Infect Dis., 2021;113: 74-81.
COVID-19 Host Genetics Initiative(Takahashi K, Harada N, Takagi H, Nakamura A, et al.). Mapping the human
genetic architecture of COVID-19. Nature., 2021;600(7889): 472-477.
Kawaguchi K, Hashimoto M, Mikawa R, Asai A, Sato T, Sugimoto M. Protocol for assessing the senescence-associated
lung pathologies. STAR Protoc. 2021 Dec 4;2(4):100993.
Fujimoto D, Miura S, Yoshimura K, Wakuda K, Oya Y, Yokoyama T, Yokoi T, Asao T, Tamiya M, Nakamura A, Yoshioka
H, Haratani K, Teraoka S, Tokito T, Murakami S, Tamiya A, Itoh S, Yokouchi H, Watanabe S, Yamaguchi O, Tomii K,
Yamamoto N. Pembrolizumab plus
chemotherapy-induced pneumonitis in chemo-naïve patients with non-squamous non-small cell lung cancer: A
multicentre, retrospective cohort study. Eur J Cancer., 2021;150: 63-72.
Miyawaki T, Kenmotsu H, Harada H, Ohde Y, Chiba Y, Haratani K, Okimoto T, Sakamoto T, Wakuda K, Ito K, Uemura T,
Sakata S, Kogure Y, Nishimura Y, Nakagawa K, Yamamoto N. Phase II study of multidisciplinary therapy combined
with pembrolizumab for patients
with synchronous oligometastatic non-small cell lung cancer TRAP OLIGO study (WJOG11118L). BMC Cancer. 2021 Oct
18;21(1):1121.
Wakuda K, Yabe M, Kodama H, Nishioka N, Miyawaki T, Miyawaki E, Mamesaya N, Kobayashi H, Omori S, Ono A,
Kenmotsu H, Naito T, Murakami H, Shimizu T, Gon Y, Takahashi T. Long-term outcomes in extensive disease small
cell lung cancer patients treated without
immune checkpoint inhibitors. Jpn J Clin Oncol., 2021;51(12): 1736-1743.
Kodama H, Kenmotsu H, Kawabata T, Notsu A, Yabe M, Nishioka N, Miyawaki E, Miyawaki T, Mamesaya N, Kobayashi H,
Omori S, Wakuda K, Ono A, Naito T, Murakami H, Takahashi T. Impact of angiogenesis inhibitor eligibility on the
prognosis of patients with
non-small cell lung cancer harboring EGFR mutation. Cancer Med., 2021;10(21): 7503-7513.
Omori S, Muramatsu K, Kawata T, Miyawaki E, Miyawaki T, Mamesaya N, Kawamura T, Kobayashi H, Nakashima K, Wakuda
K, Ono A, Kenmotsu H, Naito T, Murakami H, Sugino T, Takahashi T. Trophoblast cell-surface antigen 2 expression
in lung cancer patients and
the effects of anti-cancer treatments. J Cancer Res Clin Oncol., 2021;17. doi: 10.1007/s00432-021-03784-3.
Mamesaya N, Muramatsu K, Yabe M, Kodama H, Nishioka N, Miyawaki T, Miyawaki E, Kobayashi H, Omori S, Wakuda K,
Ono A, Kenmotsu H, Naito T, Murakami H, Harada H, Sugino T, Shimizu T, Gon Y, Takahashi T. Detection of
programmed cell death-ligand 1 using
22C3 antibody in patients with unresectable stage III non-small cell lung cancer receiving chemoradiotherapy.
Int J Clin Oncol. 2021 Apr;26(4):659-669.
Sakamoto S, Kataoka K, Kondoh Y, Kato M, Okamoto M, Mukae H, Bando M, Suda T, Yatera K, Tanino Y, Kishaba T,
Hattori N, Taguchi Y, Saito T, Nishioka Y, Kuwano K, Kishi K, Inase N, Sasaki S, Takizawa H, Johkoh T, Sakai F,
Homma S; Diffuse Lung Diseases
Research Group of the Ministry of Health, Labour and Welfare, Japan. Pirfenidone plus inhaled N-acetylcysteine
for idiopathic pulmonary fibrosis: a randomised trial. Eur Respir J., 2021;57: 2000348.
Hisata S, Bando M, Homma S, Kataoka K, Ogura T, Izumi S, Sakamoto S, Watanabe K, Saito Y, Shimizu Y, Kato M,
Nishioka Y, Hara H, Waseda Y, Tanino Y, Yatera K, Hashimoto S, Mukae H, Inase N; Diffuse Lung Diseases Research
Group of the Ministry of Health,
Labour and Welfare, Japan. Safety and tolerability of combination therapy with pirfenidone and nintedanib for
idiopathic pulmonary fibrosis: A multicenter retrospective observational study in Japan. Respir Investig.,
2021;59(6): 819-826.
Nakagawa K, Kijima T, Okada M, Morise M, Kato M, Hirano K, Fujimoto N, Takenoyama M, Yokouchi H, Ohe Y, Hida T,
Aoe K, Kishimoto T, Hirokawa M, Matsuki H, Kaneko Y, Yamada T, Morimoto C, Takeda M. Phase 2 Study of YS110, a
Recombinant Humanized Anti-CD26
Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural Mesothelioma. JTO Clin Res Rep.,
2021;2(6): 100178.
Carrot-Zhang J, Soca-Chafre G, Patterson N, Thorner AR, Nag A, Watson J, Genovese G, Rodriguez J, Gelbard MK,
Corrales-Rodriguez L, Mitsuishi Y, Ha G, Campbell JD, Oxnard GR, Arrieta O, Cardona AF, Gusev A, Meyerson M.
Genetic Ancestry Contributes to
Somatic Mutations in Lung Cancers from Admixed Latin American Populations. Cancer Discov., 2021;11(3): 591-598.
Kobayashi K, Terai H, Yasuda H, Hamamoto J, Hayashi Y, Takeuchi O, Mitsuishi Y, Masuzawa K, Manabe T, Ikemura S,
Kawada I, Suzuki Y, Soejima K, Fukunaga K. Functional dissection of the KRAS G12C mutation by comparison among
multiple oncogenic driver mutations
in a lung cancer cell line model. Biochem Biophys Res Commun., 2021;534: 1-7.
Sueoka-Aragane N, Nakashima C, Yoshida H, Matsumoto N, Iwanaga K, Ebi N, Nishiyama A, Yatera K, Kuyama S, Fukuda
M, Ushijima S, Umeguchi H, Harada D, Kashiwabara K, Suetsugu T, Fujimoto N, Tanaka F, Uramoto H, Yoshii C,
Nakatomi K, Koh G, Seki N, Aoe
K, Nosaki K, Inoue K, Takamori A, Kawaguchi A. The role of comprehensive analysis with circulating tumor DNA in
advanced non-small cell lung cancer patients considered for osimertinib treatment. Cancer Med., 2021;10(12):
3873-3885.
Ikarashi D, Okimoto T, Shukuya T, Onagi H, Hayashi T, Sinicropi-Yao SL, Amann JM, Nakatsura T, Kitano S, Carbone
DP. Comparison of Tumor Microenvironments Between Primary Tumors and Brain Metastases in Patients With NSCLC.
JTO Clin Res Rep., 2021;2(10):
100230.
Sata M, Sasaki S, Oikado K, Saito Y, Tominaga J, Sakai F, Kato T, Iwasawa T, Kenmotsu H, Kusumoto M, Baba T,
Endo M, Fujiwara Y, Sugiura H, Yanagawa N, Ito Y, Sakamoto T, Ohe Y, Kuwano K. Treatment and relapse of
interstitial lung disease in nivolumab-treated
patients with non-small cell lung cancer. Cancer Sci., 2021;112(4): 1506-1513.
Saito Y, Sasaki S, Oikado K, Tominaga J, Sata M, Sakai F, Kato T, Iwasawa T, Kenmotsu H, Kusumoto M, Baba T,
Endo M, Fujiwara Y, Sugiura H, Yanagawa N, Ito Y, Sakamoto T, Ohe Y, Kuwano K. Radiographic features and poor
prognostic factors of interstitial
lung disease with nivolumab for non-small cell lung cancer. Cancer Sci., 2021;112(4): 1495-1505.
Shimoda Y, Yoshida T, Shirasawa M, Mizuno T, Jo H, Matsumoto Y, Shinno Y, Okuma Y, Goto Y, Horinouchi H,
Yamamoto N, Yatabe Y, Ohe Y, Motoi N. Smoking History Predicts High Presence of TILs and Efficacy of PD-1
Blockade in PD-L1 Expression-negative Non-small
Cell Lung Cancer Patients. Anticancer Res., 2021;41(11): 5739-5747.
Takagi S, Sasaki Y, Koike S, Takemoto A, Seto Y, Haraguchi M, Ukaji T, Kawaguchi T, Sugawara M, Saito M,
Funauchi Y, Ae K, Matsumoto S, Fujita N, Katayama R. Platelet-derived lysophosphatidic acid mediated LPAR1
activation as a therapeutic target for
osteosarcoma metastasis. Oncogene., 2021;40(36): 5548-5558.
Harada N, Ito J, Takahashi K. Clinical effects and immune modulation of biologics in asthma. Respir Investig.,
2021;59: 389-396.
Abe S, Ito J, Harada S, Sasano H, Ueda S, Sandhu Y, Takeshige T, Katsura Y,Harada N, Takahashi K. A case of hand
urticaria, lip angioedema, and oropharyngeal pruritus induced by Japanese radish through IgE-mediated immediate
allergic reaction. Allergy
Asthma Clin Immunol. 2021; 17(1): 36.
Ueda S, Shukuya T, Hayashi T, Suzuki M, Kondo A, Aai Y, Takeshige T, Ninomiya H, Takahashi K. Transformation
from adenocarcinoma to squamous cell lung carcinoma with MET amplification after lorlatinib resistance: A case
report. Thorac Cancer., 2021;12(5):
715-719.
Miyashita Y, Hara M, Iwakami SI, Matsuda H, Iwakami N, Takahashi K. Sarcoidosis with marked necrosis in enlarged
lymph nodes mimics mycobacterial infection: a case report. J Med Case Rep., 15(1):178, 2021
Matsuda H, Hara M, Iwakami S, Takahashi K. EML4-ALK positive lung adenocarcinoma with skeletal muscle metastasis
in the right calf which was treatable with lorlatinib after resistance to treatment with alectinib. BMJ Case
Rep., 2021;14(4): e240295.
Haraguchi M, Harada N, Watanabe J, Yoshikawa H, Shirai Y, Komura M, Koyama M, Ito J, Tsukune Y, Horimoto Y,
Hayashi T, Nagaoka T, Uekusa T, Takahashi K. Disseminated nontuberculous mycobacteriosis and fungemia after
second delivery in a patient with MonoMAC
syndrome/GATA2 mutation: a case report. BMC Infect Dis., 2021;21(1): 502.
Kato M, Mori M, Miura K, Asao T, Motomura H, Nishino K, Ko R, Koyama R, Hayashi T, Takahashi K. Dramatic,
significant metabolic response to a one-time pembrolizumab treatment following a relapse of pre-existing
organizing pneumonia in a patient with advanced
non-small cell lung cancer: A case report. Thorac Cancer., 2021; 12(22): 3076-3079.
Ishida M, Hiraoka M, Yaguchi A, Sugano K, Adachi N, Itoga T, Ishiguro T, Onishi H. Naldemedine-induced opioid
withdrawal syndrome with severe psychiatric symptoms in an advanced cervical cancer patient without brain
metastasis. Palliat Support Care.,
27: 1-3, 2021
2020年
Hayakawa D, Takahashi F, Mitsuishi Y, Tajima K, Hidayat M, Winardi W, Ihara H, Kanamori K, Matsumoto N, Asao T,
Ko R, Shukuya T, Takamochi K, Hayashi T, Suehara Y, Takeda Nakamura I, Ueno T, Kohsaka S, Mano H, Takahashi K.
Activation of insulin-like growth
factor-1 receptor confers acquired resistance to osimertinib in non-small cell lung cancer with EGFR T790M
mutation. Thorac Cancer. 11(1):140-149, 2020 Jan
Hosomi Y, Morita S, Sugawara S, Kato T, Fukuhara T, Gemma A, Takahashi K, Fujita Y, Harada T, Minato K, Takamura
K, Hagiwara K, Kobayashi K, Nukiwa T, Inoue A; North-East Japan Study Group. Gefitinib Alone Versus
Gefitinib Plus Chemotherapy for Non-Small-Cell
Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study. J Clin Oncol.
38(2):115-123, 2020 Jan
Ko Y, Asakawa K, Tobino K, Oguma T, Hirai T, Takada T, Takahashi K, Seyama K; Multicenter
Lymphangioleiomyomatosis Sirolimus Trial for Safety Study Group. Quantitative analysis of computed
tomography of the lungs in patients with lymphangioleiomyomatosis
treated with sirolimus. Heliyon 6(2):e03345. 2020 Feb 6
Tateishi K, Ko R, Shukuya T, Okuma Y, Watanabe S, Kuyama S, Murase K, Tsukita Y, Ashinuma H, Nakagawa T, Uematsu
K, Nakao M, Mori Y, Kaira K, Mouri A, Miyabayashi T, Sakashita H, Matsumoto Y, Tanigawa T, Koizumi T, Morita S,
Kobayashi K, Nukiwa T, Takahashi
K; North East Japan Study Group. Clinical Outcomes of Second-Line Chemotherapy in Patients with
Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023
Study. Oncologist 25(4): e668-e674. 2020 Apr
Sekine I, Shintani Y, Shukuya T, Takayama K, Inoue A, Okamoto I, Kiura K, Takahashi K, Dosaka-Akita H, Takiguchi
Y, Miyaoka E, Okumura M, Yoshino I. A Japanese lung cancer registry study on demographics and treatment
modalities in medically treated patients.
Cancer Sci. 111(5):1685-1691, 2020 May
Wang K, Verbakel JY, Oke J, Fleming-Nouri A, Brewin J, Roberts N, Harada N, Atsuta R, Takahashi K, Mori K,
Fujisawa T, Shirai T, Kawayama T, Inoue H, Lazarus S, Szefler S, Martinez F, Shaw D, Pavord ID, Thomas M.
Using fractional exhaled nitric oxide
to guide step-down treatment decisions in patients with asthma: a systematic review and individual patient
data meta-analysis. Eur Respir J. 55(5):1902150, 2020 May
Okamoto S, Suzuki K, Hayashi T, Muraki K, Nagaoka T, Nishino K, Sekimoto Y, Sasaki S, Takahashi K, Seyama K.
Transbronchial lung biopsy for the diagnosis of lymphangioleiomyomatosis: the severity of cystic lung
destruction assessed by the modified Goddard
scoring system as a predictor for establishing the diagnosis. Orphanet J Rare Dis 15(1):125, 2020
May
Kohsaka S, Hayashi T, Nagano M, Ueno T, Kojima S, Kawazu M, Shiraishi Y, Kishikawa S, Suehara Y, Takahashi F,
Takahashi K, Suzuki K, Takamochi K, Mano H. Identification of Novel CD74-NRG2αFusion From
Comprehensive Profiling of Lung Adenocarcinoma in Japanese
Never or Light Smokers. J Thorac Oncol 15(6):948-961, 2020 Jun
Kozuki T, Nogami N, Hataji O, Tsunezuka Y, Seki N, Harada T, Fujimoto N, Bessho A, Takamura K, Takahashi K,
Satouchi M, Kato T, Shukuya T, Yamashita N, Okamoto H, Shinkai T, Thoracic Oncology Research Group.
Open-label, multicenter, randomized phase II
study on docetaxel plus bevacizumab or pemetrexed plus bevacizumab for treatment of elderly (aged ≥75
years) patients with previously untreated advanced non-squamous non-small cell lung cancer:
TORG1323. Transl Lung Cancer Res 9(3): 459-470, 2020 Jun
Ishigaki K, Akiyama M, Kanai M, Takahashi A, Kawakami E, Sugishita H, Sakaue S, Matoba N, Low SK, Okada Y, Terao
C, Amariuta T, Gazal S, Kochi Y, Horikoshi M, Suzuki K, Ito K, Koyama S, Ozaki K, Niida S, Sakata Y, Sakata Y,
Kohno T, Shiraishi K, Momozawa
Y, Hirata M, Matsuda K, Ikeda M, Iwata N, Ikegawa S, Kou I, Tanaka T, Nakagawa H, Suzuki A, Hirota T, Tamari M,
Chayama K, Miki D, Mori M, Nagayama S, Daigo Y, Miki Y, Katagiri T, Ogawa O, Obara W, Ito H, Yoshida T, Imoto I,
Takahashi T, Tanikawa C, Suzuki
T, Sinozaki N, Minami S, Yamaguchi H, Asai S, Takahashi Y, Yamaji K, Takahashi K, Fujioka T, Takata R, Yanai H,
Masumoto A, Koretsune Y, Kutsumi H, Higashiyama M, Murayama S, Minegishi N, Suzuki K, Tanno K, Shimizu A, Yamaji
T, Iwasaki M, Sawada N, Uemura
H, Tanaka K, Naito M, Sasaki M, Wakai K, Tsugane S, Yamamoto M, Yamamoto K, Murakami Y, Nakamura Y, Raychaudhuri
S, Inazawa J, Yamauchi T, Kadowaki T, Kubo M, Kamatani Y. Large-scale genome-wide association study in a
Japanese population identifies novel
susceptibility loci across different diseases. Nat Genet. 52(7):669-679, 2020 Jun
Ihara H, Mitsuishi Y, Kato M, Takahashi F, Tajima K, Hayashi T, Hidayat M, Winardi W, Wirawan A, Hayakawa D,
Kanamori K, Matsumoto N, Yae T, Sato T, Sasaki S, Takamochi K, Suehara Y, Ogura D, Niwa SI, Suzuki K, Takahashi
K. Nintedanib Inhibits Epithelial-Mesenchymal
Transition in A549 Alveolar Epithelial Cells Through Regulation of the TGF-β/Smad Pathway.
Respir Investig 58(4): 275-284, 2020 Jul
Kobayashi K, Soejima K, Fukunaga K, Shintani Y, Sekine I, Shukuya T, Takayama K, Inoue A, Okamoto I, Kiura K,
Takahashi K, Yamamoto N, Takiguchi Y, Miyaoka E, Okumura M, Yoshino I, and on behalf of the Group on behalf of
the Japanese Joint Committee of
Lung Cancer Registry. Key prognostic factors for EGFR-mutated non-adenocarcinoma lung cancer patients in
the Japanese Joint Committee of Lung Cancer Registry Database. Lung Cancer 146: 236-243, 2020 Aug
Igawa S, Naoki K, Shintani Y, Sekine I, Shukuya T, Takayama K, Inoue A, Okamoto I, Kiura K, Takahashi K,
Yamamoto N, Takiguchi Y, Miyaoka E, Okumura M, Yoshino I. Survival and Prognostic Factors in Elderly
Patients Receiving Second-line Chemotherapy for
Relapsed Small-Cell Lung Cancer: Results from the Japanese Joint Committee of Lung Cancer Registry.
Lung Cancer. 146: 160-164, 2020 Aug
Harada N, Harada S, Ito J, Atsuta R, Hori S, Takahashi K. Mobile Health App for Japanese Adult Patients
With Asthma: Clinical Observational Study. J Med Internet Res. 22(8):e19006, 2020 Aug 14
Miyawaki T, Kenmotsu H, Mori K, Miyawaki E, Mamesaya N, Kawamura T, Kobayashi H, Omori S, Wakuda K, Ono A, Naito
T, Murakami H, Harada H, Endo M, Ohde Y, Takahashi K, Takahashi T. Association Between Clinical Tumor
Burden and Efficacy of Immune Checkpoint
Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer. Clin Lung Cancer. 21(5): e405-e414,
2020 Sep
Hayashi T, Kohsaka S, Takamochi K, Hara K, Kishikawa S, Sano K, Takahashi F, Suehara Y, Saito T, Takahashi K,
Suzuki K, Yao T. Clinicopathological characteristics of lung adenocarcinoma with compound EGFR
mutations. Hum Pathol. 103:42-51, 2020 Sep
Takei S, Ihara H, Togo S, Nakamura A, Fujimoto Y, Watanabe J, Kurokawa K, Shibayama K, Sumiyoshi I, Ochi Y, Iwai
M, Okabe T, Chonan M, Misawa S, Ohsaka A, Takahashi K. The synergetic effect of Imipenem-clarithromycin
combination in the Mycobacteroides
abscessus complex. BMC Microbiol. 20(1):316, 2020 Oct 19
Okuma Y, Ko R, Shukuya T, Tateishi K, Imai H, Iwasawa S, Miyauchi E, Kojima T, Fujita Y, Hino T, Yamanda S,
Suzuki T, Fukuizumi A, Sakakibara T, Harada T, Morita S, Kobayashi K, Nukiwa T, Takahashi K; North East Japan
Study Group. Prognostic factors for
patients with metastatic or recurrent thymic carcinoma receiving palliative-intent chemotherapy.
Lung Cancer. 148:122-128, 2020 Oct
Kato M, Takahashi F, Sato T, Mitsuishi Y, Tajima K, Ihara H, Nurwidya F, Baskoro H, Murakami A, Kobayashi I,
Hidayat M, Shimada N, Sasaki S, Mineki R, Fujimura T, Kumasaka T, Niwa S, Takahashi K. Tranilast
Inhibits Pulmonary Fibrosis by Suppressing TGFβ/SMAD2
Pathway. Drug Des Devel Ther. 14: 4593-4603, 2020 Oct 29
Tsuboshima K, Kurihara M, Yamanaka T, Watanabe K, Matoba Y, Seyama K. Does a gender have something to do
with clinical pictures of primary spontaneous pneumothorax？ Gen Thorac Cardiovasc Surg.
68(8):741-745, 2020.
Suzuki K, Seyama K, Ebana H, Kumasaka T, Kuwatsuru R. Quantitative analysis of cystic lung diseases by
use of paired inspiratory and expiratory CT: estimation of the extent of cyst-airway communication and
evaluation of diagnostic utility. Radiology:
Cardiothoracic Imaging. 2: e190097, 2020
Suzuki E, Kurihara M, Tsuboshima K, Watanabe K, Okamoto S, Seyama K. The effects of total pleural
covering on pneumothorax recurrence and pulmonary function in lymphangioleiomyomatosis patients without
history of pleurodesis or thoracic surgeries for
pneumothorax. J Thorac Dis in press, 2020.
Miyazaki K, Togo S, Okamoto R, Idiris A, Kumagai H, Miyagi Y. Collective cancer cell invasion in contact
with fibroblasts through integrin-α5β1/fibronectin interaction in collagen matrix.
Cancer Sci. 2020 Sep 26.
Wang K, Verbakel JY, Oke J, Fleming-Nouri A, Harada N, Atsuta R, Fujisawa T, Kawayama T, Inoue H, Lazarus S,
Szefler S, Martinez FD, Shaw D, Pavord ID, Thomas M. Using fractional exhaled nitric oxide to guide
step-down treatment decisions in asthma: practical
considerations. Eur Respir J 2020; 56: 2002809.
Mikawa R, Sato T, Suzuki Y, Baskoro H, Kawaguchi K, Sugimoto M. p19Arf exacerbates cigarette
smoke-induced pulmonary dysfunction. Biomolecules 10(3), 462. (2020)
Llabata P, Mitsuishi Y, Choi PS, Cai D, Francis JM, Torres-Diz M, Udeshi ND, Golomb L, Wu Z, Zhou J, Svinkina T,
Aguilera-Jimenez E, Liu Y, Carr SA, Sanchez- Cespedes M, Meyerson M, Zhang X. Multi-Omics Analysis
Identifies MGA as a Negative Regulator
of the MYC Pathway in Lung Adenocarcinoma. Mol Cancer Res. 2020 Apr;18(4):574-584.
Sakamoto S, Kataoka K, Kondo Y, Kato M, Okamoto M, Mukae H, Bando M, Suda T, Yatera K, Tanino Y, Kishaba T,
Hattori N, Taguchi Y, Saito T, Nishioka Y, Kuwano K, Kishi K, Inase N, Sasaki S, Takizawa H, Johkoh T, Sakai F,
Homma S; Diffuse Lung Diseases
Research Group of the Ministry of Health, Labour and Welfare, Japan. Pirfenidone plus inhaled
N-acetylcysteine for idiopathic pulmonary fibrosis: a randomised trial. Eur Respir J. 2020 Jul
23:2000348.
Tanaka K, Morita S, Ando M, Yokoyama T, Nakamura A, Yoshioka H, Ishiguro T, Miura S, Toyozawa R, Oguri T, Daga
H, Ko R, Bessho A, Tashihara M, Iwamoto Y, Hirano K, Nakanishi Y, Nakagawa K, Yamamoto N, Okamoto I. A
randomized phase 3 study of maintenance
therapy with S-1 plus best supportive care versus best supportive care after induction therapy with
carboplatin plus S-1 for advanced or relapsed squamous cell carcinoma of the lung (WJOG7512L).
Cancer 2020; 125: 3648-3656.
Shukuya T, Ghai V, Amann JM, Okimoto T, Shilo K, Kim TK, Wang K, Carbone DP. Circulating MicroRNAs and
Extracellular Vesicle-Containing MicroRNAs as Response Biomarkers of Anti-programmed Cell Death Protein 1 or
Programmed Death-Ligand 1 Therapy in NSCLC.
J Thorac Oncol. 2020 Nov;15(11):1773-1781.
Shukuya T, Oyanagi J, Serizawa M, Watanabe M, Yamamoto N, Koh Y. Hypoxia Inducible Factor-1α
Inhibition in Von Hippel Lindau-mutant Malignant Pleural Mesothelioma Cells. Anticancer Res. 2020
Apr;40(4):1867-1874.
Yamauchi M, Nakayama H, Shiota S, Ohshima Y, Terada J, Nishijima T, Kosuga M, Kitamura T, Tachibana N, Oguri T,
Shirahama R, Aoki Y, Ishigaki K, Sugie K, Yagi T, Muraki H, Fujita Y, Takatani T, Muro S. Potential
patient screening for late-onset Pompe
disease in suspected sleep apnea: a rationale and study design for a Prospective Multicenter Observational
Cohort Study in Japan (PSSAP-J Study). Sleep Breath. 2020 Aug 18. Online ahead of print.
Sata N, Inoshita A, Suda S, Shiota S, Shiroshita N, Kawana F, Suzuki Y, Matsumoto F, Ikeda K, Kasai T.
Clinical, polysomnographic, and cephalometric features of obstructive sleep apnea with AHI over
100. Sleep Breath. 2020 Nov 17. Online ahead of print.
Nakagawa K, Hida T, Nokihara H, Morise M, Azuma K, Kim Y.K, Seto T, Takiguchi Y, Nishio M, Yoshioka H, Kumagai
T, Hotta K, Watanabe S, Goto K, Satouchi M, Kozuki T, Koyama R, Mitsudomi T, Yamamoto N, Asakawa T, Hayashi M,
Hasegawa W, Tamura T．Final progression-free
survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung
cancer. Lung Cancer., 2020 Jan; 139: 195-199.
Nakazawa Y, Sakashita A, Kaizu M, Abo H, Ise Y, Shinada Y, Sugano K, Yamashiro A, Akizuki N, Kato M. A
Self-Check Program Targeting Quality Improvement in a Hospital-Based Palliative Care Consultation Team,
Japanese Society for Palliative Medicine: Issues
Regarding Team Activities Identified through the Plan-Do-Check-Act Cycle. J Palliat Med. 2020 Mar;
23(3):359-367
Matsuda Y, Tanimukai H, Inoue S, Inada S, Sugano K, Hasuo H, Yoshimura M, Wada S, Dotani C, Adachi H, Okamoto Y,
Takeuchi M, Fujisawa D, Kako J, Sasaki C, Kishi Y, Akizuki N, Inagaki M, Uchitomi Y, Matsushima E, Okuyama T.
JPOS/JASCC clinical guidelines
for delirium in adult cancer patients: a summary of recommendation statements. Jpn J Clin Oncol
2020 May; 50(5): 586-593
Kogami M, Suzuki S, Nanjo Y, Ikeda K, Tamura N, Sasaki S, Morimoto S. Complication of coronavirus
disease 2019 during remission induction therapy against anti-MDA5 antibody-positive
dermatomyositis. Rheumatol Adv Pract. 4(2): rkaa068, 2020 Nov
Sugiyama AI, Shiota S, Yamada T, Ito J, Suzuki K, Takahashi K. Sleep-related breathing disorders
associated with the characteristics of underlying congenital rare diseases of Moebius syndrome and Poland
syndrome. Respirol Case Rep 8(5): e00579, 2020 May
Jingo K, Harada N, Nishioki T,Torasawa M,Yamada T, Asao T, Takagi T,Takeshige T, Ito J, Takahashi K.
Anaphylaxis to three humanized antibodies for severe asthma: A case study. Allergy Asthma Clin
Immunol. 10;16:46. eCollection 2020 Jun
Kato Y, Kato M, Ihara H, Hayakawa E, Shibayama K, Miura K, Yamada T, Mitsuishi Y, Shukuya T, Ito J, Matsunaga T,
Sato T, Suzuki K, Takahashi K. Hermansky-Pudlak syndrome-associated pneumothorax with rapid progression
of respiratory failure: a case report.
BMC Pulm Med. 20(1):259, 2020 Oct
Nishioki T, Kato M, Kataoka S, Miura K, Nagaoka T, Takahashi K. Atezolizumab‐induced fulminant type 1
diabetes mellitus occurring four months after treatment cessation. Respirology Case Reports.
8(9):doi.org/10.1002/rcr2.685, 20020 Oct
Kurokawa K, Harada N, Sasano H, Takahagi H, Takei S, Nakamura A, Kamada K, Yoshida A, Kikuchi K, Takahashi K.
Pulmonary infection due to fluoroquinolone-resistant Mycolicibacterium fortuitum: a case
report. BMC Infectious Diseases. 20: 866, 2020 Nov
Ochi Y, Kato M, Fujioka M, Hayashi M, Takagi H, Takahashi K. Thrombocytopaenia during nintedanib
treatment in a patient with idiopathic pulmonary fibrosis. Respirol Case Rep. 2020, 8: e00628.
Kurata K, Matsumoto H, Jimbo N, Yakushijin K, Yamamoto K, Ito M, Nakamachi Y, Matsuoka H, Saegusa J, Seyama K,
Itoh T, Minami H. Lymphoplasmacytic lymphoma in a patient with Birt-Hogg-Dubé syndrome.
Int J Hematol. 2020 Dec;112(6):864-870.
Hayashi T, Takamochi K, Kohsaka S, Kishikawa S, Suehara Y, Takahashi F, Suzuki K, Saito T. Spontaneous
transformation from EGFR/PTEN co-mutated lung adenocarcinoma to small cell carcinoma in lymph node
metastasis. Pathol Int 70(5):295-299 (2020)
Kumakawa Y, Hirano Y, Sueyoshi K, Ishihara T, Kondo Y, Kawasaki T, Takeuchi Y, Nakamura Y, Ishikawa K, Watanabe
Y, Saito W, Matsuda S, Nakazawa T, Sasaki S, Okamoto K, Hiroshi T. Late i.v. steroid treatment for
severe COVID-19-induced acute respiratory
distress syndrome: a case report. Acute Med Surg., 7(1): e569, 2020 Sep
Hayama N, Ihara H, Honma Y, Itoigawa Y, Kaira K, Fujii M: Severe gastritis due to pembrolizumab
treatment in a lung cancer patient. Respirol Case Rep. 8(7) : e00636, 2020 Oct
2019年
Tsutsumi T, Nagaoka T, Yoshida T, Wang L, Kuriyama S, Suzuki Y, Nagata Y, Harada N, Kodama Y, Takahashi F, Morio
Y, Takahashi K. Nintedanib ameliorates experimental pulmonary arterial hypertension via inhibition of
endothelial mesenchymal transition and
smooth muscle cell proliferation. PLoS one 24;14(7):e0214697. eCollection 2019.
Kadoya K, Togo S, Tulafu M, Namba Y, Iwai M, Watanabe J, Okabe T, Jin J, Kodama Y, Kitamura H, Ogura T, Kitamura
N, Ikeo K, Takeda T, Kondo N, Takahashi K. Specific features of fibrotic lung fibroblasts highly
sensitive to fibrotic processes mediated
via TGF-β-ERK5 interaction. Cell Physiol Biochem. 52(4):822-837, 2019 Jun
Tajima K, Matsuda S, Yae T, Drapkin BJ, Morris R, Boukhali M, Niederhoffer K, Comaills V, Dubash T, Nieman L,
Guo H, Magnus NKC, Dyson N, Shioda T, Haas W, Haber DA, Maheswaran S. SETD1A protects from senescence
through regulation of the mitotic gene
expression program. Nat Commun. 2019 Jun 28;10(1):2854.
Shukuya T, Yamada T, Koenig MJ, Xu J, Okimoto T, Li F, Amann JM, Carbone DP. The Effect of LKB1 Activity
on the Sensitivity to PI3K/mTOR Inhibition in Non-Small Cell Lung Cancer. J Thorac Oncol. 2019
Jun;14(6):1061-1076. Epub 2019
Kitajima S, Ivanova E, Guo S, Yoshida R, Campisi M, Sundararaman SK, Tange S, Mitsuishi Y, Thai TC, Masuda S,
Piel BP, Sholl LM, Kirschmeier PT, Paweletz CP, Watanabe H, Yajima M, Barbie DA. Suppression of STING
Associated with LKB1 Loss in KRAS-Driven
Lung Cancer. Cancer Discov. 2019 Jan;9(1):34-45. Epub 2018 Oct 8.
Kohsaka S, Tatsuno K, Ueno T, Nagano M, Shinozaki-Ushiku A, Ushiku T, Takai D, Ikegami M, Kobayashi H, Kage H,
Ando M, Hata K, Ueda H, Yamamoto S, Kojima S, Oseto K, Akaike K, Suehara Y, Hayashi T, Saito T, Takahashi F,
Takahashi K, Takamochi K, Suzuki
K, Nagayama S, Oda Y, Mimori K, Ishihara S, Yatomi Y, Nagase T, Nakajima J, Tanaka S, Fukayama M, Oda K, Nangaku
M, Miyazono K, Miyagawa K, Aburatani H, Mano H. Comprehensive assay for the molecular profiling of
cancer by target enrichment from formalin-fixed
paraffin-embedded specimens. Cancer Sci. 110(4):1464-1479, 2019 Apr
Koike K, Berdyshev EV, Mikosz AM, Bronova IA, Bronoff AS, Jung JP, Beatman EL, Ni K, Cao D, Scruggs AK, Serban
KA, Petrache I. Role of Glucosylceramide in Lung Endothelial Cell Fate and Emphysema. Am J
Respir Crit Care Med. 2019 Nov 1;200(9):1113-1125.
doi: 10.1164/rccm.201812-2311OC.
Kato M, Sasaki S, Nakamura T, Kurokawa K, Yamada T, Ochi Y, Ihara H, Takahashi F, Takahashi K.
Gastrointestinal adverse effects of nintedanib and the associated risk factors in patients with
idiopathic pulmonary fibrosis. Scientific Reports 19;9(1):12062.
2019.
Kato M, Sasaki S, Kurokawa K, Nakamura T, Yamada T, Sasano H, Arano N, Komura M, Ihara H, Nagashima O, Shiota S,
Takahashi F, Takahashi K. Usual interstitial pneumonia pattern in the lower lung lobes as a prognostic
factor in idiopathic pleuroparenchymal
fibroelastosis. Respiration. 97(4):319-328, 2019 Jan
Tateishi K, Ko R, Shukuya T, Okuma Y, Watanabe S, Kuyama S, Murase K, Tsukita Y, Ashinuma H, Nakagawa T, Uematsu
K, Nakao M, Mori Y, Kaira K, Mouri A, Miyabayashi T, Sakashita H, Matsumoto Y, Tanigawa T, Koizumi T, Morita S,
Kobayashi K, Nukiwa T, Takahashi
K; North East Japan Study Group. Clinical Outcomes of Second-Line Chemotherapy in Patients with
Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023
Study. Oncologist. 2019 Nov 26. pii: theoncologist.2019-0593.
[Epub ahead of print]
Seyama K, Nukiwa T, Sato T, Suzuki M, Konno S, Takahashi K, Nishimura M, Steinmann K, Sorrells S, Chen J,
Hayashi KI. Safety and pharmacokinetics of Alpha-1 MP (Prolastin®-C) in Japanese patients with
alpha1-antitrypsin (AAT) deficiency. Respir Investig.
57(1):89-96, 2019 Jan
Yamaguchi Y, Shiota S, Kusunoki Y, Hamaya H, Ishii M, Kodama Y, Akishita M, Kida K, Takahashi K, Nagase T,
Fukuchi Y. Polysomnographic features of low arousal threshold in overlap syndrome involving obstructive
sleep apnea and chronic obstructive pulmonary
disease. Sleep Breath. 2019 Jan 26. [Epub ahead of print]
Tanabe Y, Harada N, Ito J, Matsuno K, Takeshige T, Harada S, Takemasa M, Kotajima M, Ishimori A, Katsura Y,
Makino F, Atsuta R, Takahashi K. Difference between two exhaled nitric oxide analyzers, NIOX VERO®
electrochemical hand-held analyzer and NOA280i®
chemiluminescence stationary analyzer. J Asthma. 56(2):167-172, 2019 Feb
Kuwasaki E, Nagaoka T, Ihara H, Tsutsumi T, Nakamura A, Yoshikawa H, Yoshida T, Watanabe J, Ichikawa M, Koyama
R, Shimada N, Takahashi K. Age is an independent predictor in pathological diagnosis of sarcoidosis: a
retrospective analysis of diagnosis by
endobronchial ultrasound-guided transbronchial needle aspiration. J Thorac Dis. 11(5):2175-2180,
2019 May
Hidayat M, Mitsuishi Y, Takahashi F, Tajima K, Yae T, Miyahara K, Hayakawa D, Winardi W, Ihara H, Koinuma Y,
Wirawan A, Nurwidya F, Kato M, Kobayashi I, Sasaki S, Takamochi K, Hayashi T, Suehara Y, Moriyama M, Moriyama H,
Habu S, Takahashi K. Role of
FBXW7 in the quiescence of gefitinib-resistant lung cancer stem cells in EGFR-mutant non-small cell lung
cancer. Bosn J Basic Med Sci. 2019 May 28. [Epub ahead of print]
Jin J, Togo S, Kadoya K, Tulafu M, Namba Y, Iwai M, Watanabe J, Nagahama K, Okabe T, Hidayat M, Kodama Y,
Kitamura H, Ogura T, Kitamura N, Ikeo K, Sasaki S, Tominaga S, Takahashi K. Pirfenidone attenuates lung
fibrotic fibroblast responses to transforming
growth factor-β1. Respir Res. 20(1):119, 2019 Jun 11
Nanjo Y, Newstead MW, Aoyagi T, Zeng X, Takahashi K, Yu FS, Tateda K, Standiford TJ. Overlapping Roles
for Interleukin-36 Cytokines in Protective Host Defense against Murine Legionella pneumophila
Pneumonia. Infect Immun. 19;87(1). pii: e00583-18. 2019
Zuoyou L, Shiota S, Morio Y, Sugiyama A, Sekiya M, Iwakami SI, Ienaga H, Fukuchi Y, Takahashi K.
Borderline pulmonary hypertension associated with chronic hypercapnia in chronic pulmonary
disease. Respir Physiol Neurobiol. 2019 Apr;262:20-25. Epub 2019
Ihara H, Kikuchi K, Taniguchi H, Fujita S, Tsuruta Y, Kato M, Mitsuishi Y, Tajima K, Kodama Y, Takahashi F,
Takahashi K, Azuma N. 23-valent pneumococcal polysaccharide vaccine improves survival in dialysis
patients by preventing cardiac events. Vaccine.
2019 Oct 8;37(43):6447-6453. Epub 2019
Karasutani K, Baskoro H, Sato T, Arano N, Suzuki Y, Mitsui A, Shimada N, Kodama Y, Seyama K, Fukuchi Y,
Takahashi K. Lung Fixation under Constant Pressure for Evaluation of Emphysema in Mice. J Vis
Exp. 2019 Sep 26;(151).
Shoji T, Konno S, Niida Y, Ogi T, Suzuki M, Shimizu K, Hida Y, Kaga K, Seyama K, Naka T, Matsuno Y, Nishimura M.
Familial multifocal micronodular pneumocyte hyperplasia with a novel splicing mutation in TSC1: Three
cases in one family. PLoS One. 2019
Feb 22;14(2):e0212370. eCollection 2019.
Oba S, Inaba Y, Shibuya T, Oshima J, Seyama K, Kobayashi T, Kunugita N, Ino T. Changes in oxidative
stress levels during two weeks of smoking cessation treatment and their association with nutritional
characteristics in Japanese smokers. Exp Ther Med.
2019 Apr;17(4):2757-2764. Epub 2019
Tsuyama S, Saito T, Akazawa Y, Yanai Y, Yatagai N, Akaike K, Hayashi T, Suehara Y, Takahashi F, Takamochi K,
Hashimoto T, Kajiyama Y, Tsurumaru M, Fukunaga T, Yao T. Molecular and clinicopathological analyses of
esophageal carcinosarcoma with special
reference to morphological change. Virchows Archiv ;475(4):415-424. Epub 2019 Aug 23.
Suehara Y, Okubo T, Kurihara T, Hayashi T, Kohsaka S, Kazuno S, Sano K, Hasegawa N, Miura Y, Akaike K, Kim Y,
Takamochi K, Takahashi F, Ueno T, Kaneko K, Saito T. Protein Expression Profiles Corresponding to
Histological Changes with Denosumab Treatment
in Giant Cell Tumors of Bone. Proteomics Clin Appl. e1800147. (2019)
Miyazaki K, Oyanagi J, Hoshino D, Togo S, Kumagai H, Miyagi Y. Cancer cell migration on elongate
protrusions of fibroblasts in collagen matrix. Sci Rep. 2019 Jan 22;9(1):292.
Maruyama N, Takai T, Kamijo S, Suchiva P, Ohba M, Takeshige T, Suzuki M, Hara M, Matsuno K, Harada S, Harada N,
Nakae S, Sudo K, Okuno T, Yokomizo T, Ogawa H, Okumura K, Ikeda S. Cyclooxygenase inhibition in mice
heightens adaptive- and innate-type responses
against inhaled protease allergen and IL-33. Allergy. 2019 Nov;74(11):2237-2240. Epub 2019
Mizugaki H, Hamada A, Shibata T, Hosoda F, Nakamura H, Okuma Y, Shukuya T, Umemura S, Horiike A, Fukui T, Kogure
Y, Daga H, Urata Y, Yamada K, Saeki S, Fujisaka Y, Nakamura Y, Sato M, Yoshida T, Hotta T, Oizumi S, Fujiwara Y,
Ohe Y, Fujiwara Y. Exploration
of germline variants responsible for adverse events of crizotinib in anaplastic lymphoma kinase-positive
non-small cell lung cancer by target-gene panel sequencing. Lung Cancer. 2019 Feb;128:20-25.
Yoh K, Takamochi K, Shukuya T, Hishida T, Tsuboi M, Sakurai H, Goto Y, Yoshida K, Ohde Y, Okumura S, Ohashi Y,
Kunitoh H. Pattern of care in adjuvant therapy for resected Stage I non-small cell lung cancer:
real-world data from Japan. Jpn J Clin Oncol.
2019 Jan 1;49(1):63-68.
Kenmotsu H, Yoh K, Mori K, Ono A, Baba T, Fujiwara Y, Yamaguchi O, Ko R, Okamoto H, Yamamoto N, Ninomiya T,
Ogura T, Kato T. Phase II study of nab-paclitaxel + carboplatin for patients with non-small-cell lung
cancer and interstitial lung disease. Cancer
Sci. 2019 Dec;110(12):3738-3745.
Nakashima K, Kimura M, Akamatsu H, Daga H, Imai H, Taira T, Ko R, Hisamatsu Y, Nishino K, Sugimoto T, Miyashita
Y, Takahashi T. Osimertinib for patients with EGFR T790M mutation-positive non-small-cell lung cancer
and a poor performance status. Jpn J
Clin Oncol. 2019 Jul 1;49(7):671-675.
Okazaki S, Umene K, Yamasaki J, Suina K, Otsuki Y, Yoshikawa M, Minami Y, Masuko T, Kawaguchi S, Nakayama H,
Banno K, Aoki D, Saya H, Nagano O. Glutaminolysis-related genes determine sensitivity to xCT-targeted
therapy in head and neck squamous cell carcinoma.
Cancer Sci. 2019 Nov;110(11):3453-3463.
Koike K, Beatman EL, Schweitzer KS, Justice MJ, Mikosz AM, Ni K, Clauss MA, Petrache I. Subcutaneous
administration of neutralizing antibodies to endothelial monocyte-activating protein II attenuates cigarette
smoke-induced lung injury in mice. Am J Physiol
Lung Cell Mol Physiol. 2019 Mar 1;316(3):L558-L566.
Baba T, Akai F. S, Kato T, Kusumoto M, Kenmotsu H, Sugiura H, Tominaga J, Oikado K, Sata M, Endo M, Yanagawa N,
Sasaki S, Iwasawa T, Saito Y, Fujiwara Y, Ohe Y, Yamazaki N, Sakamoto T, Koshiba T, Kuwano K. Radiologic
features of pneumonitis associated
with nivolumab in non-small-cell lung cancer and malignant melanoma. Future Oncol., 2019 Jun;
15(16): 1911-1920.
Murata K, Inoue Y, Kaiho M, Nakazawa T, Sasaki S, Miyake K, Matsuda S, Tanaka H. Genomic analysis of
antibiotic resistance for Acinetobacter baumannii in a critical care center. Acute Med Surg., 2019
Jul; 7(1): e445.
Kato M, Yamada T, Kataoka S, Arai Y, Miura K, Ochi Y, Ihara H, Koyama R, Sasaki S, Takahashi K.
Prognostic differences among patients with idiopathic interstitial pneumonias with acute exacerbation of
varying pathogenesis: a retrospective study. Respir
Res. 2019 Dec 18;20(1):287.
Sasaki S, Kato M, Nakamura K, Namba Y, Nagashima O, Takahashi K. Management of skin sarcoidosis with
minocycline monotherapy. Respirol Case Rep. 2019 Mar 13;7(4):e00413, 2019 Mar eCollection 2019 May.
Kurokawa K, Asao T, Ko R, Nagaoka T, Suzuki K, Takahashi K. Severe mediastinitis over a month after
endobronchial ultrasound-guided transbronchial needle aspiration. Respirol Case Rep. 2019 Apr
9;7(5):e00426. eCollection 2019 Jul
Kurokawa K, Hara H, Iwakami S, Genda T, Iwakami N, Miyashita Y, Fujioka M, Sasaki S, Takahashi K.
Cholestatic Liver Injury Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma. Intern
Med 58(22):3283-3287. Epub 2019 Nov 15.
2018年
Yasuda M, Harada N, Harada S, Ishimori A, Katsura Y, Itoigawa Y, Matsuno K, Makino F, Ito J, Ono J, Tobino K,
Akiba H, Atsuta R, Izuhara K, Takahashi K. Characterization of tenascin-C as a novel biomarker for asthma:
utility of tenascin-C in combination
with periostin or immunoglobulin E. Allergy Asthma Clin Immunol 2018; 14: 72.
Kanemaru R, Takahashi F, Kato M, Mitsuishi Y, Tajima K, Ihara H, Hidayat M, Wirawan A, Koinuma Y, Hayakawa D,
Yagishita S, Ko R, Sato T, Harada N, Kodama Y, Nurwidya F, Sasaki S, Niwa SI, Takahashi K. Dasatinib Suppresses
TGFbeta-Mediated Epithelial-Mesenchymal
Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis. Lung 2018;196(5):531-541.
Glowacka WK, Jain H, Okura M, Maimaitiming A, Mamatjan Y, Nejad R, Farooq H, Taylor MD, Aldape K, Kongkham P.
5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant
high-grade glioma. Acta Neuropathol. 2018 Apr;135(4):617-634.
Horimoto Y, Tokuda E, Murakami F, Uomori T, Himuro T, Nakai K, Orihata G, Iijima K, Togo S, Shimizu H, Saito M.
Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based
treatment in 22 patients with
metastatic breast cancer: a pilot study. J Transl Med. 2018 Oct 20;16(1):287. doi: 10.1186/s12967-018-1663-8.
Miharu Kato, Yumiko Kanehiro, Kaku Yoshimi, Yuzo Kodama, Mitsuaki Sekiya, Tadashi Sato, Kazuhisa Takahashi,
Kuniaki Seyama. COPD assessment test as a possible tool for evaluating health-related quality of life in
lymphangioleiomyomatosis Respiratory Investigation,
2018;56；480-488.
Miharu Kato, Mitsuaki Sekiya, Yohei Suzuki, Tadashi Sato, Masako Ichikawa, Yuzo Kodama, Kuniaki Seyama, Eri
Aikawa-Hirasawa, Kazuhisa Takahashi. Evaluation of Physical Activity in Patients with Chronic Obstructive
Pulmonary Disease Using an Accelerometer
with Tapestry-Style Display Capability. Juntendo Medical Journal 2018;64: (4): 286-294.
Kato M, Sasaki S, Kurokawa K, Nakamura T, Yamada T, Sasano H, Arano N, Komura M, Ihara H, Nagashima O, Shiota S,
Takahashi F, Takahashi K. Usual Interstitial Pneumonia Pattern in the Lower Lung Lobes as a Prognostic Factor in
Idiopathic Pleuroparenchymal
Fibroelastosis. Respiration. 2018 Dec 6:1-10. doi: 10.1159/000494061.
Takahashi K, Ueda S, Kobayashi T, Nishiyama A, Fujisawa Y, Sugaya T, Shiota S, Takahashi K, Gohda T, Horikoshi
S, Suzuki Y. Chronic intermittent hypoxia-mediated renal sympathetic nerve activation in hypertension and
cardiovascular disease. Sci Rep. 2018
Dec 18;8(1):17926. doi: 10.1038/s41598-018-36159-9.
Mikawa R, Suzuki Y, Baskoro H, Kanayama K, Sugimoto K, Sato T, Sugimoto M. Elimination of p19ARF-expressing
cells protects against pulmonary emphysema in mice. Aging Cell, 2018;17(5):e12827.
Kobayashi K, Miki Y, Saito R, Adachi K, Seyama K, Okada Y, Sasano H. Roles of human epidermal growth factor
receptor family in pulmonary lymphangioleiomyomatosis Hum Pathol. 2018 Nov;81:121-130.
Oishi H, Watanabe T, Matsuda Y, Noda M, Ejima Y, Saiki Y, Seyama K, Kondo T, Okada Y. Single lung
transplantation for lymphangioleiomyomatosis: a single-center experience in Japan. Surg Today. 2018
Oct;48(10):944-950.
Callea F, Giovannoni I, Francalanci P, Boldrini R, Faa G, Medicina D, Nobili V, Desmet VJ, Ishak K, Seyama K,
Bellacchio E. Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency.
Orphanet J Rare Dis. 2018 May
16;13(1):79.
Mizobuchi T, Kurihara M, Ebana H, Yamanaka S, Kataoka H, Okamoto S, Kobayashi E, Kumasaka T, Seyama K. A total
pleural covering of absorbable cellulose mesh prevents pneumothorax recurrence in patients with
Birt-Hogg-Dubé syndrome. Orphanet J Rare Dis.
2018 May 15;13(1):78.
Iwabuchi C, Ebana H, Ishiko A, Negishi A, Mizobuchi T, Kumasaka T, Kurihara M, Seyama K. Skin lesions of
Birt-Hogg-Dubé syndrome: Clinical and histopathological findings in 31 Japanese patients who presented
with pneumothorax and/or multiple lung cysts.
J Dermatol Sci. 2018 Jan;89(1):77-84.
Mina Y,Norihiro H. Characterization of tenascin-C as a novel biomarker for asthma: Utility of tenascin-C in
combination with periostin or immunoglobulin E. Allergy Asthma Clin Immunol. 2018;14:72.
Watanabe M, Kenmotsu H, Ko R, Wakuda K, Ono A, Imai H, Taira T, Naito T, Murakami H, Abe M, Endo M, Nakajima T,
Koh Y, Takahashi T. Isolation and molecular analysis of circulating tumor cells from lung cancer patients using
a microfluidic chip type cell
sorter. Cancer Sci. 2018; 109(8): 2539-2548.
Kamei R, Yoshimura K, Yoshino S, Inoue M, Asao T, Fuse M, Wada S, Kuramasu A, Furuya-Kondo T, Oga A, Iizuka N,
Suzuki N, Maeda N, Watanabe Y, Matsukuma S, Iida M, Takeda S, Ueno T, Yamamoto N, Fukagawa T, Katai H, Sasaki H,
Hazama S, Oka M, Nagano H.
Expression levels of UL16 binding protein 1 and natural killer group 2 member D affect overall survival in
patients with gastric cancer following gastrectomy. Oncol Lett 2018; 15(1): 747-754.
Otani H, Takahashi A, Kato K, Kano N, Watanabe D, Yoshioka R, Fujikawa S, Hongo T, Sugahara R, Hisanaga M, Hirai
Y, Mita T, Suzuki K, Takahashi K. Aim and future perspectives of the tropical medicine association of Juntendo
University through the activity
of the 53rd south east asia research group. Juntendo Medical Journal, 2018; 64(1): 59-63
Ebana H, Mizobuchi T, Kurihara M, Kobayashi E, Haga T, Okamoto S, Takahashi K, Seyama K. Novel clinical scoring
system to identify patients with pneumothorax with suspicion for Birt-Hogg-Dubé syndrome. Respirology,
2018; 23(4):414-418
Ebana H, Hayashi T, Mitani K, Kobayashi E, Kumasaka T, Mizobuchi T, Kurihara M, Takahashi F, Takahashi K, Seyama
K. Oxidized regenerated cellulose induces pleural thickening in patients with pneumothorax: possible involvement
of the mesothelial-mesenchymal
transition. Surg Today, 2018; 48(4):462-472
Ihara H, Harada N, Shimada N, Kanamori K, Hayashi T, Uekusa T, Takahashi K. A Case of Malignant Pleural
Mesothelioma with Bone Marrow Metastases. Intern Med, 2018; 57(17):2541-2545
Ko R, Shukuya T, Okuma Y, Tateishi K, Imai H, Iwasawa S, Miyauchi E, Fujiwara A, Sugiyama T, Azuma K, Muraki K,
Yamasaki M, Tanaka H, Takashima Y, Soda S, Ishimoto O, Koyama N, Morita S, Kobayashi K, Nukiwa T, Takahashi K;
North East Japan Study Group.
Prognostic Factors and Efficacy of First-Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A
Retrospective Analysis of 286 Patients from NEJ023 Study. Oncologist, 2018; 23(10):1210-1217
Iwakami N, Iwakami SI, Hara M, Sekiya M, Dambara T, Takahashi K. The diagnostic yield using ultrasound-guided
needle-aspiration for subpleural primary lung cancer is not affected by the radiological properties of the
lesions resulting from computed tomography.
Respir Investig. 2018; 56(3):238-242
Watanabe J, Togo S, Sumiyoshi I, Namba Y, Suina K, Mizuno T, Kadoya K, Motomura H, Iwai M, Nagaoka T, Sasaki S,
Hayashi T, Uekusa T, Abe K, Urata Y, Sakurai F, Mizuguchi H, Kato S, Takahashi K. Clinical features of squamous
cell lung cancer with anaplastic
lymphoma kinase (ALK)-rearrangement: a retrospective analysis and review. Oncotarget. 2018; 9(35):24000-24013
Homma S, Bando M, Azuma A, Sakamoto S, Sugino K, Ishii Y, Izumi S, Inase N, Inoue Y, Ebina M, Ogura T, Kishi K,
Kishaba T, Kido T, Gemma A, Goto Y, Sasaki S, Johkoh T, Suda T, Takahashi K, Takahashi H, Taguchi Y, Date H,
Taniguchi H, Nakayama T, Nishioka
Y, Hasegawa Y, Hattori N, Fukuoka J, Miyamoto A, Mukae H, Yokoyama A, Yoshino I, Watanabe K; Ministry of Health,
Labour and Welfare, the Study Group on Diffuse Pulmonary Disorders, Scientific Research/Research on Intractable
Diseases, and Japanese Respiratory
Society. Japanese guideline for the treatment of idiopathic pulmonary fibrosis. Respir Investig. 2018;
56(4):268-291
Yamada T, Iwakami SI, Hara SAM, Iwakami N, Nakamura A, Suzuki Y, Sasaki SI, Takahashi K. Disseminated
non-tuberculous mycobacterial infection caused by anti-interferon-γ autoantibodies in a patient of very
advanced age. Geriatr Gerontol Int. 2018; 18(7):1132-1133
Baskoro H, Sato T, Karasutani K, Suzuki Y, Mitsui A, Arano N, Nurwidya F, Kato M, Takahashi F, Kodama Y, Seyama
K, Takahashi K. Regional heterogeneity in response of airway epithelial cells to cigarette smoke. BMC Pulm Med.
2018; 4;18(1):148
Matsuno K, Harada N, Harada S, Takeshige T, Ishimori A, Itoigawa Y, Katsura Y, Kodama Y, Makino F, Ito J, Atsuta
R, Akiba H, Takahashi K. Combination of TWEAK and TGF-β1 induces the production of TSLP, RANTES, and TARC
in BEAS-2B human bronchial epithelial
cells during epithelial-mesenchymal transition. Exp Lung Res. 2018; 44(7):332-343
Komura M, Yagishita S, Nakamura K, Arano N, Takeshige T, Muraki K, Nagashima O, Izumi H, Tomita S, Sasaki S,
Takahashi K. A Case of a Pregnant Woman Diagnosed as Having ALK-rearranged Lung Adenocarcinoma.In Vivo. 2018;
32(5):1205-1209
F
Hara M, Iwakami SI, Sumiyoshi I, Yoshida T, Sasaki S, Takahashi K. Hydrocarbon pneumonitis caused by the
inhalation of wood preservative. Respirol Case Rep. 2018; 26;6(9):e00379
Nanjo Y, Newstead MW, Aoyagi T, Zeng X, Takahashi K, Yu FS, Tateda K, Standiford TJ. Overlapping Roles for
Interleukin-36 Cytokines in Protective Host Defense against Murine Legionella pneumophila Pneumonia. Infect
Immun. 2018; 19;87(1)
Suina K, Tsuchihashi K, Yamasaki J, Kamenori S, Shintani S, Hirata Y, Okazaki S, Sampetrean O, Baba E, Akashi K,
Mitsuishi Y, Takahashi F, Takahashi K, Saya H, Nagano O. Epidermal growth factor receptor promotes glioma
progression by regulating xCT and
GluN2B-containing N-methyl-d-aspartate-sensitive glutamate receptor signaling. Cancer Sci. 2018;
109(12):3874-3882
Ishii M, Suehara Y, Kohsaka S, Hayashi T, Kazuno S, Tanabe Y, Akaike K, Mukaihara K, Kim Y, Okubo T, Takamochi
K, Takahashi F, Kaneko K, Saito T. Proteomic signatures corresponding to the SS18/SSX fusion gene in synovial
sarcoma. Oncotarget 25;9(101):37509-37519.
(2018)
Akazawa Y, Saito T, Hayashi T, Yanai Y, Tsuyama S, Akaike K, Suehara Y, Takahashi F, Takamochi K, Murakami T,
Watanabe S. Yao T. Next-generation sequencing analysis for gastric adenocarcinoma with enteroblastic
differentiation: emphasis on the relationship
with hepatoid adenocarcinoma. Human pathology 78:79-88. (2018)
Akaike K, Suehara Y, Kohsaka S, Hayashi T, Tanabe Y, Kazuno S, Mukaihara K, Toda-Ishii M, Okubo T, Hayashi Y,
Takamoch K, Takahashi F, Kaneko K, Saito T. PPP2R1A regulated by PAX3/FOXO3 fusion contributes to the
acquisition of aggressive behavior in PAX3/FOXO1-positive
alveolar rhabdomyosarcoma. Oncotarget 18;9(38):25206-25215. (2018)
Hayashi T, Takamochi K, Yanai Y, Mitani K, Tomita H, Mogushi K, Suehara Y, Takahashi F, Suzuki K, Saito T, Yao
T. Non-small cell lung carcinoma with diffuse co-expression of thyroid transcription factor-1 and
ΔNp63/p40. Human pathology 78:177-181. (2018)
Zhang X, Choi PS, Francis JM, Gao GF, Campbell JD, Ramachandran A, Mitsuishi Y, Ha G, Shih J, Vazquez F,
Tsherniak A, Taylor AM, Zhou J, Wu Z, Berger AC, Giannakis M, Hahn WC1, Cherniack AD, Meyerson M. Somatic
Superenhancer Duplications and Hotspot Mutations
Lead to Oncogenic Activation of the KLF5 Transcription Factor. Cancer Discov. 2018 Jan;8(1):108-125.
Hirano T, Ohkouchi S, Tode N, Kobayashi M, Ono M, Satoh T, Mitsuishi Y, Watanabe A, Tabata M, Irokawa T, Ogawa
H, Sugiura H, Kikuchi T, Akasaka K, Tazawa R, Inoue Y, Nakata K, Kurosawa H, Ichinose M. Peripheral alveolar
nitric oxide concentration reflects
alveolar inflammation in autoimmune pulmonary alveolar proteinosis. ERJ Open Res. 2018 Mar 23;4(1). pii:
00071-2017.
Okazaki S, Shintani S, Hirata Y, Suina K, Semba T, Yamasaki J, Umene K, Ishikawa M, Saya H, Nagano O. Synthetic
lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer
cells. Oncotarget. 2018 Sep 18;9(73):33832-33843.
hiota M, Naya M, Yamamoto T, Hishiki T, Tani T, Takahashi H, Kubo A, Koike D, Itoh M, Ohmura M, Kabe Y, Sugiura
Y, Hiraoka N, Morikawa T, Takubo K, Suina K, Nagashima H, Sampetrean O, Nagano O, Saya H, Yamazoe S, Watanabe H,
Suematsu M. Gold-nanofève
surface-enhanced Raman spectroscopy visualizes hypotaurine as a robust anti-oxidant consumed in cancer survival.
Nat Commun. 2018 Apr 19;9(1):1561.
Yamada T, Amann JM, Tanimoto A, Taniguchi H, Shukuya T, Timmers C, Yano S, Shilo K, Carbone DP. Histone
Deacetylase Inhibition Enhances the Antitumor Activity of a MEK Inhibitor in Lung Cancer Cells Harboring RAS
Mutations. Mol Cancer Ther. 2018 Jan;17(1):17-25.
2017年
Kohsaka S, Nagano M, Ueno T, Suehara Y, Hayashi T, Shimada N, Takahashi K, Suzuki K, Takamochi K, Takahashi F,
Mano H.
A method of high-throughput functional evaluation of EGFR gene variants of unknown significance in cancer.
Sci Transl Med. 2017 Nov 15;9(416).
Zhang X, Choi PS, Francis JM, Gao GF, Campbell JD, Ramachandran A, Mitsuishi Y, Ha G, Shih J, Vazquez F,
Tsherniak A, Taylor AM, Zhou J, Wu Z, Berger AC, Giannakis M, Hahn WC, Cherniack AD, Meyerson M.
Somatic super-enhancer duplications and hotspot mutations lead to oncogenic activation of the KLF5
transcription factor.
Cancer Discov. 2017 Sep 29. pii: CD-17-0532.
Hida T, Nokihara H, Kondo M, Kim YH, Azuma K, Seto T, Takiguchi Y, Nishio M, Yoshioka H, Imamura F, Hotta K,
Watanabe S, Goto K, Satouchi M, Kozuki T, Shukuya T, Nakagawa K, Mitsudomi T, Yamamoto N, Asakawa T, Asabe R,
Tanaka T, Tamura T.
Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an
open-label, randomised phase 3 trial.
Lancet. 2017 Jul 1;390(10089):29-39.
Okamoto S, Togo S, Nagata I, Shimizu K, Koinuma Y, Namba Y, Ito J, Uekusa T, Takahashi K. Lung adenocarcinoma
expressing receptor for advanced glycation end-products with primary systemic AL amyloidosis: a case report and
literature review. BMC Cancer.
17(1):22. doi: 10.1186/s12885-016-3009-3, 2017 Jan 3.265
Namba Y, Togo S, Tulafu M, Kadoya K, Nagahama KY, Taka H, Kaga N, Orimo A, Liu XD, Takahashi K. Combination of
glycopyrronium and indacaterol inhibits carbachol-induced ERK5 signal in fibrotic processes. Respiratory
Research. 18(1):46, 2017 Mar 11
Ishimori A, Harada N, Chiba A, Harada S, Matsuno K, Makino F, Ito J, Ohta S, Ono J, Atsuta R, Izuhara K,
Takahashi K, Miyake S. Circulating activated innate lymphoid cells and mucosal-associated invariant T cells are
associated with airflow limitation
in patients with asthma. Allergol Int. 66(2): 302-309, 2017 Apr 2.355
Nishino K, Yoshimi K, Shibuya T, Hayashi T, Mitani K, Kobayashi E, Ichikawa M, Asao T, Suzuki Y, Sato T, Shiota
S, Kodama Y, Takahashi K, Seyama K. Protein-losing Enteropathy Caused by Intestinal or Colonic Lymphangiectasia
Complicated by Sporadic Lymphangioleiomyomatosis:
A Report of Two Cases.Intern Med. 56(8):943-948, 2017 Apr 15.
Arano N, Morio Y, Futagawa T, Hashizume A, Nagashima O, Sasaki SI, Tominaga S, Takahashi K. Lung metastases from
cutaneous adenoid cystic carcinoma 23 years after initial treatment. Respir Med Case Rep. 21:121-123, 2017 Apr
19
Yamada T, Amann JM, Tanimoto A, Taniguchi H, Shukuya T, Timmers C, Yano S, Shilo K, Carbone DP.
Histone deacetylase inhibition enhances the antitumor activity of a MEK inhibitor in lung cancer cells
harboring RAS mutations.
Mol Cancer Ther. 2017 Oct 27. pii: molcanther.0146.2017.
Shukuya T, Patel S, Shane-Carson K, He K, Bertino EM, Shilo K, Otterson GA, Carbone DP.
Lung Cancer Patients with Germline Mutations Detected by Next-Generation Sequencing and/or Liquid Biopsy.
J Thorac Oncol. 2017 Oct 5. pii: S1556-0864(17)32764-8.
Otsubo K, Nosaki K, Imamura CK, Ogata H, Fujita A, Sakata S, Hirai F, Toyokawa G, Iwama E, Harada T, Seto T,
Takenoyama M, Ozeki T, Mushiroda T, Inada M, Kishimoto J, Tsuchihashi K, Suina K, Nagano O, Saya H, Nakanishi Y,
Okamoto I.
Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced
non-small-cell lung cancer.
Cancer Sci. 2017 Sep;108(9):1843-1849.
Ohta T, Mita M, Hishinuma S, Ishii-Nozawa R, Takahashi K, Shoji M. Inhibition of ectopic arginine vasopressin
production by phenytoin in the small cell lung cancer cell line Lu-165. Original Research. 2017 April 28. doi:
10.3389/fendo.2017.00094
Ai T, Yuri M, Tabe Y, Kakimoto A, Morishita S, Tsuchiya K, Takamochi K, Kodama Y, Takahashi F, Shigeki M, Horii
T, Suzuki K, Takahashi K, Miida T, Ohsaka A. Comparison of the Analytical Performance Between cobas EGFR Assay
and PCR-Clamp Method in the
Detection of EGFR Mutations in Japanese Non-Small Cell Lung Cancer Patients. Clin Lab. 63(5):1021-1026, 2017 May
1
Nakamura K, Kato M, Shukuya T, Mori K, Sekimoto Y, Ihara H, Kanemaru R, Ko R, Shibayama R, Tajima K, Koyama R,
Shimada N, Nagashima O, Takahashi F, Sasaki S, Takahashi K. Surfactant protein-D predicts prognosis of
interstitial lung disease induced by
anticancer agents in advanced lung cancer: a case control study.BMC Cancer. 17(1):302.doi:
10.1186/s12885-017-3285-6. 2017 May 2
Togo S, Katagiri N, Namba Y, Tulafu M, Nagahama K, Kadoya K, Takamochi K, Oh S, Suzuki K, Sakurai F, Mizuguchi
H, Urata Y, Takahashi K. Sensitive detection of viable circulating tumor cells using a novel conditionally
telomerase-selective replicating
adenovirus in non-small cell lung cancer patients. Oncotarget. 8(21):34884-34895, 2017 May 23
Okamoto S, Komura M, Terao Y, Kurisaki-Arakawa A, Hayashi T, Saito T, Togo S, Shiokawa A, Mitani K, Kobayashi E,
Kumasaka T, Takahashi K, Seyama K. Pneumothorax caused by cystic and nodular lung metastases from a malignant
uterine perivascular epithelioid
cell tumor (PEComa).Respir Med Case Rep. 22:77-82, 2017 Jun 27
Asao T, Fujiwara Y, Itahashi K, Kitahara S, Goto Y, Horinouchi H, Kanda S, Nokihara H, Yamamoto N, Takahashi K,
Ohe Y. Sequential Use of Anaplastic Lymphoma Kinase Inhibitors in Japanese Patients With ALK-Rearranged
Non-Small-Cell Lung Cancer: A Retrospective
Analysis. Clin Lung Cancer. 18(4): e251-e258, 2017 Jul 3.030
Takaeshige T, Harada N, Sekimoto Y, Kanemaru R, Tsutsumi T, Matsuno K, Shiota S, Masuda A, Gotoh A, Asahina M,
Uekusa T, Takahashi K. Pulmonary Intravascular large B-cell lymphoma(IVLBCL) disguised as an Asthma exacerbation
in a patient with asthma. Intern
Med. 56: 1885-1891, 2017
Kodama Y, Kishimoto Y, Muramatsu Y, Tatebe J, Yamamoto Y, Hirota N, Itoigawa Y, Atsuta R, Koike K, Sato T,
Aizawa K, Takahashi K, Morita T, Homma S, Seyama K, Ishigami A. Antioxidant nutrients in plasma of Japanese
patients with chronic obstructive pulmonary
disease (COPD), asthma-COPD overlap syndrome, and bronchial asthma. Clin Respir J. 2015 Dec 14. doi:
10.1111/crj.12436. [Epub ahead of print] 1.512
Nurwidya F, Takahashi F, Kato M, Baskoro H, Hidayat M, Wirawan A, Takahashi K. CD44 silencing decreases the
expression of stem cell-related factors induced by transforming growth factor β1 and tumor necrosis factor
α in lung cancer: Preliminary findings.
Bosn J Basic Med Sci. 2017 Apr 24. doi: 10.17305/bjbms.2017.1966. [Epub ahead of print]
Sandhu Y, Ando K, Takekawa H, Takagi H, Hirama M, Kido K, Takahashi K.
Safety of Bronchoscopy for Patients Undergoing Hemodialysis.
Respir Investig. 2017 Mar;55(2):173-175.
Yoshikawa H, Fujii M, Iwakami SI, Takeda I, Hayakawa D, Takahashi K.
Chylothorax ascribed to chronic heart failure in a woman of very advanced years.
Geriatr Gerontol Int. 2017 Jul;17(7):1133-1135.
Suzuki Y, Sato T, Sugimoto M, Baskoro H, Karasutani K, Mitsui A, Nurwidya F, Arano N, Kodama Y, Hirano SI,
Ishigami A, Seyama K, Takahashi K.
Hydrogen-rich pure water prevents cigarette smoke-induced pulmonary emphysema in SMP30 knockout mice.
Biochem Biophys Res Commun. 2017 Oct 7;492(1):74-81.
Honma Y, Togo S, Shimizu K, Tulafu M, Hayashi T, Uekusa T, Tominaga S, Kido K, Fujimoto Y, Nanba Y, Takamochi K,
Oh S, Suzuki K, Takahashi K.
Expression of thymidylate synthase predicts clinical outcomes of S-1-based chemotherapy in squamous cell
lung cancer.
Oncol Lett. 2017 Sep;14(3):3319-3326.
Jotatsu T, Yagishita S, Tajima K, Takahashi F, Mogushi K, Hidayat M, Wirawan A, Ko R, Kanemaru R, Shimada N,
Mitani K, Saito T, Takamochi K, Suzuki K, Kohsaka S, Kojima S, Mukae H, Yatera K, Takahashi K.
LSD1/KDM1 isoform LSD1+8a contributes to neural differentiation in small cell lung cancer.
Biochem Biophys Rep. 2016 Dec 1;9:86-94.
Ebana H, Mizobuchi T, Kurihara M, Kobayashi E, Haga T, Okamoto S, Takahashi K, Seyama K.
Novel clinical scoring system to identify patients with pneumothorax with suspicion for
Birt-Hogg-Dubé syndrome.
Respirology. 2017 Sep 27. doi: 10.1111/resp.13191. [Epub ahead of print]
Ebana H, Hayashi T, Mitani K, Kobayashi E, Kumasaka T, Mizobuchi T, Kurihara M, Takahashi F, Takahashi K, Seyama
K.
Oxidized regenerated cellulose induces pleural thickening in patients with pneumothorax: possible
involvement of the mesothelial-mesenchymal transition.
Surg Today. 2017 Oct 12. doi: 10.1007/s00595-017-1597-4. [Epub ahead of print]
Nakamura K, Kato M, Miyashita Y, Nagashima O, Sasaki S, Tominaga S, Takahashi K.
Development of interstitial pneumonia during treatment with eribulin: a case report.
BMC Res Notes. 2017 Nov 6;10(1):557.
Tobino K, Hirai T, Johkoh T, Fujimoto K, Kawaguchi A, Tomiyama N, Takahashi K, Seyama K.
Difference of the progression of pulmonary cysts assessed by computed tomography among COPD,
lymphangioleiomyomatosis, and Birt-Hogg-Dubé syndrome.
PLoS One. 2017 Dec 8;12(12):e0188771.
Takamochi K, Takahashi F, Suehara Y, Kitano S, Sato E, Kohsaka S, Hayashi T, Mano H, Suzuki K.
DNA mismatch repair deficiency in surgically resected lung adenocarcinoma: Microsatellite instability
analysis using the Promega panel Lung Cancer.
Lung Cancer 110:26-31. (2017)
Iwabuchi C, Ebana H, Ishiko A, Negishi A, Mizobuchi T, Kumasaka T, Kurihara M, Seyama K.
Skin lesions of Birt-Hogg-Dubé syndrome: Clinical and histopathological findings in 31 Japanese
patients who presented with pneumothorax and/or multiple lung cysts.
J Dermatol Sci. 2017 Nov 2. pii: S0923-1811(17)30462-0.
Gupta N, Finlay GA, Kotloff RM, Strange C, Wilson KC, Young LR, Taveira-DaSilva AM, Johnson SR, Cottin V, Sahn
SA, Ryu JH, Seyama K, Inoue Y, Downey GP, Han MK, Colby TV, Wikenheiser-Brokamp KA, Meyer CA, Smith K, Moss J,
McCormack FX; ATS Assembly on
Clinical Problems.
Lymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial
Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society
Clinical Practice Guideline.
Am J Respir Crit Care Med. 2017 Nov 15;196(10):1337-1348.
Kitamura N, Seyama K, Inoue Y, Nagai K, Suzuki M, Moriyama H, Takada T, Tazawa R, Hirai T, Mishima M, Hayashida
M, Hirose M, Arai T, Sugimoto C, Hattori N, Watanabe K, Tamada T, Akazawa K, Tanaka T, Nakata K.
Risk factors for stomatitis in patients with lymphangioleiomyomatosis during treatment with sirolimus: A
multicenter investigator-initiated prospective study.
Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1182-1189.
Onodera K, Sugiura H, Yamada M, Koarai A, Fujino N, Yanagisawa S, Tanaka R, Numakura T, Togo S, Sato K, Kyogoku
Y, Hashimoto Y, Okazaki T, Tamada T, Kobayashi S, Yanai M, Miura M, Hoshikawa Y, Okada Y, Suzuki S, Ichinose M.
Decrease in an anti-ageing factor, growth differentiation factor 11, in chronic obstructive pulmonary
disease.
Thorax. 2017 Oct;72(10):893-904.
Saito M, Fujiwara Y, Asao T, Honda T, Shimada Y, Kanai Y, Tsuta K, Kono K, Watanabe S, Ohe Y, Kohno T.
The genomic and epigenomic landscape in thymic carcinoma.
Carcinogenesis. 2017 Oct 26;38(11):1084-1091.
Konagai A, Yoshimura K, Hazama S, Yamamoto N, Aoki K, Ueno T, Fujioka M, Iijima H, Kato M, Uchida M, Wada T,
Inoue M, Asao T, Fuse M, Wada S, Kuramasu A, Kamei R, Takeda S, Yamamoto S, Yoshino S, Oka M, Nagano H.
Correlation Between NKG2DL Expression and Antitumor Effect of Protein-bound Polysaccharide-K in
Tumor-bearing Mouse Models.
Anticancer Res. 2017 Aug;37(8):4093-4101.
Nakamichi S, Horinouchi H, Asao T, Goto Y, Kanda S, Fujiwara Y, Nokihara H, Yamamoto N, Ito Y, Watanabe SI, Ohe
Y.
Comparison of Radiotherapy and Chemoradiotherapy for Locoregional Recurrence of Non-small-cell Lung Cancer
Developing After Surgery.
Clin Lung Cancer. 2017 Nov;18(6):e441-e448.
Okuma HS, Horinouchi H, Kitahara S, Asao T, Sunami K, Goto Y, Kanda S, Fujiwara Y, Nokihara H, Yamamoto N, Ohe
Y.
Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung
Cancer.
Clin Lung Cancer. 2017 Mar;18(2):234-240.
Shitara K, Doi T, Nagano O, Fukutani M, Hasegawa H, Nomura S, Sato A, Kuwata T, Asai K, Einaga Y, Tsuchihashi K,
Suina K, Maeda Y, Saya H, Ohtsu A.
Phase 1 study of sulfasalazine and cisplatin for patients with CD44v-positive gastric cancer refractory to
cisplatin (EPOC1407).
Gastric Cancer. 2017 Nov;20(6):1004-1009.
Ikari J, Nelson AJ, Obaid J, Giron-Martinez A, Ikari K, Makino F, Iwasawa S, Gunji Y, Farid M, Wang X, Basma H,
Demeo D, Feghali-Bostwick C, Holz O, Rabe K, Liu X, Rennard SI.
Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary
disease.
PLoS One. 2017 Sep 7;12(9):e0184039.
2016年
Ando K, Okada Y, Akiba M, Kondo T, Kawamura T, Okumura M, Chen F, Date H, Shiraishi T, Iwasaki A, Yamasaki N,
Nagayasu T, Chida M, Inoue Y, Hirai T, Seyama K, Mishima M and the Respiratory Failure Research Group of the
Japanese Ministry of Health, Labour,
and Welfare.
Lung transplantation for lymphangioleiomyomatosis in Japan.
PLos One 2016; 11(1): e0146749.
Fujita A, Ando K, Kobayashi E, Mitani K, Okudera K, Nakashima M, Miyatake S, Tsurusaki Y, Saitsu H, Seyama K,
Miyake N, Matsumoto N.
Detection of low-prevalence somatic TSC2 mutations in sporadic pulmonary lymphangioleiomyomatosis tissues by
deep sequencing.
Hum Genet. 2016,135(1):61-8.
Gunji-Niitsu Y, Kumasaka T, Kitamura S, Hoshika Y, Hayashi T, Tokuda H, Morita R, Kobayashi E, Mitani K, Kikkawa
M, Takahashi K, Seyama K.
Benign clear cell sugar tumor of the lung in a patient with Birt-Hogg-Dub? syndrome: a case report.
BMC Med Genet. 2016,17(1):85.
Jotatsu, T., Yagishita, S., Tajima, K., Takahashi, F., Mogushi, K., Hidayat, M., Wirawan, A., Ko, R., Kanemaru,
R., Shimada, N., Mitani, K., Saito, T., Takamochi, K., Suzuki, K., Kohsaka, S., Kojima, S., Mukae, H., Yatera,
K., and Takahashi, K.LSD1/KDM1
isoform LSD1+8a contributes to neural differentiation in small cell lung cancer.
Biochemical and biophysical research communications. 2016;473(1):125-132.
Kato M, Sasaki S, Sekimoto Y, Arano N, Jo H, Suina K, Kuriyama S, Muraki K, Nagashima O, Yoshioka Y,
Tominaga S, Takahashi K.
Loxoprofen-induced interstitial pneumonia: a case report.
J Med Case Rep. 2016,10(1):128.
Ko R, Kenmotsu H, Serizawa M, Koh Y, Wakuda K, Ono A, Taira T, Naito T, Murakami H, Isaka M, Endo M, Nakajima T,
Ohde Y, Yamamoto N, Takahashi K, Takahashi T
Frequency of EGFR T790M mutatoin and multimutational profiles of rebiopsy samples from non-small cell lung
cancer developing acquired resistance to EGFR tryosine kinase inhibitors in Japanese patients
BMC cancer, 2016; 16(1): 864
Kobayashi I, Takahashi F, Nurwydia F, Nara T, Hashimoto M, Murakami A, Yagishita S, Tajima K, Hidayat M, Shimada
N, Suina K, Yoshioka Y, Sasaki S, Moriyama M, Moriyama H, Takahashi K.
Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells.
Biochem Biophys Res Commun. 2016,22;473(1):125-32.
Koyama R, Takahashi K.
Non-Small-Cell lung cancer treatment: cytotoxic chemotherapy, molecular targeted therapy, and immunotherapy.
untendo Medical Journal,2016, 62(1): 7-12.
Kato M, Morio Y, Matsunaga T, Shiraishi A, Uekusa T, Takahashi K.
Bronchial-pulmonary arterial fistula with primary racemose hemangioma.
Respirol Case Rep. 2016,4(2):e00148.
Nurwidya F, Takahashi F, Takahashi K.
Gefitinib in the treatment of nonsmall cell lung cancer with activating epidermal growth factor receptor
mutation.
J Nat Sci Biol Med. 2016,7(2):119-23.
Sekimoto Y, Kato M, Shukuya T, Koyama R, Nagaoka T, Takahashi K.
Bevacizumab-induced chronic interstitial pneumonia during maintenance therapy in non-small cell lung cancer.
Respirol Case Rep. 2016 ,4(2):e00151.
Ebana H, Otsuji M, Mizobuchi T, Kurihara M, Takahashi K, Seyama K.
Pleural Covering Application for Recurrent Pneumothorax in a Patient with Birt-Hogg-Dub? Syndrome.
Ann Thorac Cardiovasc Surg.2016, 22(3):189-92.
Fukui M, Takamochi K, Matsunaga T, Oh S, Ando K, Suzuki K, Arakawa A, Uekusa T, Suzuki K.
Risk of the preoperative underestimation of tumour size of lung cancer in patients Hayashida M, Yasuo M,
Hanaoka M, Seyama K, Inoue Y, Tatsumi K, Mishima M; Respiratory Failure Research Group of the Ministry of
Health, Labour, and Welfare, Japan.
Reductions in pulmonary function detected in patients with lymphangioleiomyomatosis: An analysis of the
Japanese National Research Project on Intractable Diseases database.
Respir Investig. 2016,54(3):193-200.
Ebana H, Otsuji M, Mizobuchi T, Kurihara M, Takahashi K, Seyama K.
Pleural Covering Application for Recurrent Pneumothorax in a Patient with Birt-Hogg-Dub? Syndrome.
Ann Thorac Cardiovasc Surg. 2016,22(3):189-92.
Sakurai F, Narii N, Tomita K, Togo S, Takahashi K, Machitani M, Tachibana M, Ouchi M, Katagiri N, Urata Y,
Fujiwara T, Mizuguchi H.
Efficient detection of human circulating tumor cells without significant production of false-positive cells
by a novel conditionally replicating adenovirus.
Mol Ther Methods Clin Dev. 2016,3:16001.
Sawada T, Watanabe M, Fujimura Y, Yagishita S, Shimoyama T, Maeda Y, Kanda S, Yunokawa M, Tamura K, Tamura T,
Minami H, Koh Y, Koizumi F.
Sensitive cytometry based system for enumeration, capture and analysis of gene mutations of circulating
tumor cells.
Cancer Sci. 2016,107(3):307-14.
Seyama K, Hirai T, Mishima M, Tatsumi K, Nishimura M; Respiratory Failure Research Group of the Japanese
Ministry of Health, Labour, and Welfare.
A nationwide epidemiological survey of alpha1-antitrypsin deficiency in Japan.
Respir Investig. 2016,54(3):201-6.
Yamada K, Ichiki M, Takahashi K, Hisamatsu Y, Takeoka H, Azuma K, Shukuya T, Nishikawa K, Tokito T, Ishii H,
Hoshino T.
A multicenter phase II trial of S-1 combined with bevacizumab after platinum-based chemotherapy in patients
with advanced non-squamous non-small cell lung cancer
Cancer Chemother Pharmacol. 2016,78(3):501-7.
Yoshimi K, Oh S, Suzuki K, Kodama Y, Sekiya M, Seyama K, Fukuchi Y.
Impact of Airflow Limitation on Comorbidities and Postoperative Complications in Patients Undergoing
Thoracic Surgery: A Retrospective Observationa
Ann Thorac Cardiovasc Surg. 2016,22(3):146-52.
Hoshika Y, Takahashi F, Togo S, Hashimoto M, Nara T, Kobayashi T, Nurwidya F, Kataoka H, Kurihara M, Kobayashi
E, Ebana H, Kikkawa M, Ando K, Nishino K, Hino O, Takahashi K, Seyama K.
Haploinsufficiency of the folliculin gene leads to impaired functions of lung fibroblasts in patients with
Birt-Hogg-Dub? syndrome.
Physiol Rep. 2016,4(21). pii: e13025.
Kato M, Sasaki S, Izumi H, Uekusa T, Tominaga S, Takahashi K.
Development of diffuse alveolar damage after initiation of Nijutsuto.
Respirol Case Rep. 2016,25;4(6):e00195.
Ando K, Nakashita T, Kaneko N, Takahashi K, Motojima S.
Associations between peripheral blood eosinophil counts in patients with systemic sclerosis and disease
severity.
Springer Plus 2016,5: 1401.
Nakashita T, Ando K, Takahashi K, Motojima S.
Possible effect of abatacept on the progression of interstitial lung disease in rheumatoid arthritis
patients.
Respiratory Investigation. 2016,54(5): 376-379.
Comaills V, Kabeche L, Morris R, Buisson R, Yu M, Madden MW, LiCausi JA, Boukhali M, Tajima K, Pan S, Aceto N,
Sil S, Zheng Y, Sundaresan T, Yae T, Jordan NV, Miyamoto DT, Ting DT, Ramaswamy S, Haas W, Zou L, Haber DA,
Maheswaran S
Genomic Instability Is Induced by Persistent Proliferation of Cells Undergoing Epithelial-to-Mesenchymal
Transition
Cell Rep. 2016,6;17(10):2632-2647
McCormack FX, Gupta N, Finlay GR, Young LR, Taveira-DaSilva AM, Glasgow CG, Steagall WK, Johnson SR, Sahn SA,
Ryu JH, Strange C, Seyama K, Sullivan EJ, Kotloff RM, Downey GP, Chapman JT, Han MK, D'Armiento JM, Inoue Y,
Henske EP, Bissler JJ, Colby TV,
Kinder BW, Wikenheiser-Brokamp KA, Brown KK, Cordier JF, Meyer C, Cottin V, Brozek JL, Smith K, Wilson KC, Moss
J; ATS/JRS Committee on LymphangioleiomyomatosisOfficial American Thoracic Society/Japanese Respiratory Society
Clinical Practice Guidelines:
Lymphangioleiomyomatosis Diagnosis and Management.
Am J Respir Crit Care Med. 2016,15;194(6):748-61
Shigematsu, M., T. Koga, A. Ishimori, K. Saeki, Y. Ishii, Y. Taketomi, M. Ohba, A. Jo-Watanabe, T. Okuno, N.
Harada, T. Harayama, H. Shindou, J. D. Li, M. Murakami, S. Hoka, and T. Yokomizo.
Leukotriene B4 receptor type 2 protects against pneumolysin-dependent acute lung injury. Sci Rep, 2016; 6:
34560.
Shigeru Tominaga
Clinic-based lung cancer screening in Urayasu
Juntendo Medical Journal 2016;62(6):455-459.
Ishimori A, Harada N, Chiba A, Harada S, Matsuno K, Makino F, Ito J, Ohta S, Ono J, Atsuta R, Izuhara K,
Takahashi K, Miyake S.
Circulating activated innate lymphoid cells and mucosal-associated invariant T cells are associated with
airflow limitation in patients with asthma.
Allergol Int. 2016 Aug 26.
Hishida T, Miyaoka E, Yokoi K, Tsuboi M, Asamura H, Kiura K, Takahashi K, Dosaka-Akita H, Kobayashi H, Date H,
Tada H, Okumura M, Yoshino I.
Lobe-Specific Nodal Dissection for Clinical Stage I and II NSCLC: Japanese Multi-Institutional Retrospective
Study Using a Propensity Score Analysis.
J Thorac Oncol. 2016,11(9):1529-37.
Jiang L, Konishi H, Nurwidya F, Takahashi F, Ebinuma H, Fujimura K, Takasu K, Jiang M, Bujo H, Daida H.
Deletion of smooth muscle cell migration regulator LR11 attenuates the hypoxia- induced pulmonary arterial
remodeling with medial thickening in mice.
Arterioscler Thromb Vasc Biol 2016,36(9):1972-9.
Kurihara M, Mizobuchi T, Kataoka H, Sato T, Kumasaka T, Ebana H, Yamanaka S, Endo R, Miyahashira S, Shinya N,
Seyama K.
A Total Pleural Covering for Lymphangioleiomyomatosis Prevents Pneumothorax Recurrence.
PLoS One. 2016,22;11(9):e0163637
Ando K, Fujino N, Mitani K, Ota C, Okada Y, Kondo T, Mizobuchi T, Kurihara M, Suzuki K, Hoshika Y, Ebana H,
Kobayashi E, Takahashi K, Kubo H, Seyama K.
Isolation of individual cellular components from lung tissues of patients with lymphangioleiomyomatosis.
Am J Physiol Lung Cell Mol Physiol. 2016;310(10):L899-908.
Kato M, Shukuya T, Mori K, Kanemaru R, Honma Y, Nanjo Y, Muraki K, Shibayama R, Koyama R, Shimada N, Takahashi
F, Takahashi K.
Cerebral infarction in advanced non-small cell lung cancer: a case control study.
BMC Cancer. 2016,10;16:203.
Okuma HS, Horinouchi H, Kitahara S, Asao T, Sunami K, Goto Y, Kanda S, Fujiwara Y, Nokihara H, Yamamoto N, Ohe
Y.
Comparison of amrubicin and weekly cisplatin/etoposide/irinotecan in patients with relapsed small-cell lung
cancer.
Clin Lung Cancer 2016 Oct 25.
Shukuya T, Mori K, Amann JM, Bertino EM, Otterson GA, Shields PG, Morita S, Carbone DP.
Relationship between Overall Survival and Response or Progression-Free Survival in Advanced Non-Small Cell
Lung Cancer Patients Treated with Anti-PD-1/PD-L1 Antibodies.
J Thorac Oncol. 2016,11(11):1927-1939.
Takada T, Mikami A, Kitamura N, Seyama K, Inoue Y, Nagai K, Suzuki M, Moriyama H, Akasaka K, Tazawa R, Hirai T,
Mishima M, Hayashida M, Hirose M, Sugimoto C, Arai T, Hattori N, Watanabe K, Tamada T, Yoshizawa H, Akazawa K,
Tanaka T, Yagi K, Young LR,
McCormack FX, Nakata K.
Efficacy and Safety of Long-Term Sirolimus Therapy for Asian Patients with Lymphangioleiomyomatosis.
Ann Am Thorac Soc. 2016,13(11):1912-1922.
Asao T, Fujiwara Y, Itahashi K, Kitahara S, Goto Y, Horinouchi H, Kanda S, Nokihara H, Yamamoto N, Ohe Y.
Sequential use of anaplastic lymphoma kinase inhibitors in Japanese patients with ALK-rearranged
non-small-cell lung cancer Sequential use of anaplastic lymphoma kinase inhibitors in Japanese patients with
ALK-rearranged non-small-cell lung cancer: A
retrospective analysis.
Clin Lung Cancer 2016 Dec 7
Hashimoto M, Asai A, Kawagishi H, Mikawa R, Iwashita Y, Kanayama K, Sugimoto K, Sato T, Maruyama M, Sugimoto M.
Elimination of p19ARF-expressing cells enhances pulmonary function in mice
JCI Insight, 2016;1(12):e87732
Yamane Y, Shiono A, Ishii Y, Isobe K, Miyauchi E, Kishi K, Nishino M, Sugawara S, Ko R, Koyama N, Yabuki Y,
Kobayashi K
Treatment and outcomes of advanced/recurrent non-small cell lung cancer harboring the EGFR T790M mutation: a
retrospective observational study of 141 patients in Japan
Jpn J Clin Oncol, 2016,46(12): 1135-1142
Atsuta R, To Y, Sakamoto S, Mukai I, Kobayashi A, Kinoshita A, Takahashi K.
Assessing usability of the Adherence Starts with Knowledge 20 (ASK-20) questionnaire for Japanese adults
with bronchial asthma receiving inhaled corticosteroids long term.
Allergol Int. pii: S1323-8930(16)30150-2, 2016.
Hayashi T, Kumasaka T, Mitani K, Okada Y, Kondo T, Date H, Chen F, Oto T, Miyoshi S, Shiraishi T, Iwasaki A,
Hara K, Saito T, Ando K, Kobayashi E, Gunji-Niitsu Y, Kunogi M, Takahashi K, Yao T, Seyama K.
Bronchial involvement in advanced stage lymphangioleiomyomatosis: histopathologic and molecular analyses.
Hum Pathol. 2016,50:34-42.
Katsuya Y, Horinouchi H, Asao T, Kitahara S, Goto Y, Kanda S, Fujiwara Y, Nokihara H, Yamamoto N, Watanabe S,
Tsuta K, Ohe Y.
Expression of programmed death 1 (PD-1) and its ligand (PD-L1) in thymic epithelial tumors: Impact on
treatment efficacy and alteration in expression after chemotherapy.
Lung Cancer 2016; 99: 4-10.
Kentaro Suina , Takehito Shukuya, , Ryo Koyama , Tetsuhiko Asao , Yuichiro Honma , Motoyasu Kato , Keiko Muraki
, Rina Shibayama , Naoko Shimada , Fumiyuki Takahashi , Shoko Sakuraba , Kazuhisa Takahashi
Risk factors for serious adverse events due to cytotoxic chemotherapy for advanced non-small cell lung
cancer.
Cancer Treatment and Research Communications 2016;19:106
Kodama Y, Kishimoto Y, Muramatsu Y, Tatebe J, Yamamoto Y, Hirota N, Itoigawa Y, Atsuta R, Koike K, Sato T,
Aizawa K, Takahashi K, Morita T, Homma S, Seyama K, Ishigami A
Antioxidant nutrients in plasma of Japanese patients with chronic obstructive pulmonary disease (COPD),
asthma-COPD overlap syndrome, and bronchial asthma.
The Clinical Respiratory Journal2016 ISSN 1752-6981
